homocysteine and Coronary Disease

homocysteine has been researched along with Coronary Disease in 485 studies

Research

Studies (485)

TimeframeStudies, this research(%)All Research%
pre-19906 (1.24)18.7374
1990's154 (31.75)18.2507
2000's278 (57.32)29.6817
2010's38 (7.84)24.3611
2020's9 (1.86)2.80

Authors

AuthorsStudies
Chen, Z; Fan, L; Gao, BH; Li, Q; Yuan, XF; Zhang, B; Zhang, L1
Hua, N; Liu, C; Wang, C; Zhang, Y1
Broncel, M; Chałubiński, M; Chmiela, M; Gonciarz, W; Kaca, W; Lechowicz, Ł; Rechciński, T; Urbaniak, M1
Guo, H; He, M; Jiang, J; Long, P; Mo, T; Niu, R; Peng, R; Shi, L; Wang, Q; Wang, Y; Wu, T; Xu, C; Yang, H; Zhang, X1
Cai, X; Li, N; Luo, Q; Ren, Y; Wang, G; Wang, M; Yao, L; Yue, N; Zhao, J1
Bai, L; Du, Y; Han, K; Lu, Q; Wang, TZ; Zhu, WJ1
Du, B; Huang, X; Li, D; Ren, B; Yue, L; Zhang, C; Zhang, W; Zhao, Q1
Jiang, Y; Shi, Y; Xu, H; Yu, K; Zhang, G; Zhang, X1
Guan, J; Pan, L; Wu, L; Xiao, Q1
Elsamanoudy, AZ; Gaballah, MA; Saafan, FA; Shaalan, D; Zeidan, N1
Li, L; Liu, H; Liu, J; Shang, G; Wang, H; Zhao, H; Zhou, Y1
Cui, BB; Fu, RL; Geng, HH; Jin, YP; Li, B; Wang, JJ; Wang, PX; Wang, Q; Zhang, Q1
Chen, Z; Dong, Y; Kang, Y; Shao, L; Tian, Y; Wang, J; Wang, X; Wang, Z; Zhang, L; Zheng, C1
Guo, R; Jin, Z; Ma, J; Sun, C; Yan, P; Yang, B1
Fang, S; Wu, J; Zhou, C1
Berg, C; Björck, L; Blennow, K; de Faire, U; Leander, K; Lissner, L; Mehlig, K; Nyberg, F; Rosengren, A; Strandhagen, E; Thelle, D; Tognon, G; Torén, K; Zetterberg, H1
Aizawa, T; Funase, Y; Ouchi, K; Sato, Y; Yamauchi, K1
Assendelft, WJ; Blom, HJ; Blom, JW; de Craen, AJ; de Ruijter, W; Drewes, YM; Ford, I; Gussekloo, J; Poortvliet, RK; Sattar, N; Stott, DJ; Westendorp, RG; Wouter Jukema, J1
Ebadi, M; Esteghamati, A; Hafezi-Nejad, N; Nakhjavani, M; Sheikhbahaei, S; Zandieh, A1
Agarwal, I; Bertoia, ML; Cahill, LE; Jensen, MK; Mukamal, KJ; Rimm, EB1
Chen, Y; Hong, C; Riley, RD1
Fan, Y; Man, CF; Peng, HY; Xu, J1
Jensen, MK; Kraft, P; Mukamal, KJ; Pai, JK; Pers, TH; Rimm, EB1
Chen, S; Chen, Z; Duan, S; Fan, R; Han, L; Hao, Y; Li, R; Liu, S; Liu, Y; Ma, J; Peng, X; Wang, C; Wu, Q; Zhang, L; Zhang, T; Zhao, J1
Chen, S; Chen, Z; Han, L; Liu, S; Ma, J; Peng, X; Wang, C; Zhao, D1
Feng, L; Nian, S; Xu, W; Ye, D; Zhang, S; Zhang, X; Zheng, L1
Chen, S; Chen, Y; Guo, X; Qian, H; Sun, G; Sun, Y; Zhang, N1
Aldámiz-Echevarría, L; Couce, ML; Fernández-Marmiesse, A; Hermida, A; Leis, R; Llarena, M; Roca, I; Sánchez-Pintos, P; Vitoria, I1
Ariogul, S; Aytemir, K; Barak, A; Cankurtaran, M; Dede, DS; Halil, M; Kabakci, G; Karabulut, E; Oto, A; Ulger, Z; Yavuz, B; Yavuz, BB1
Bayraktar, N; Esinler, I; Kulaksizoglu, S; Oktem, M; Ozcimen, EE; Pamuk, B; Uckuyu, A; Zeyneloglu, HB1
Ayhan, E; Bulur, S; Can, G; Hergenç, G; Küçükdurmaz, Z; Onat, A1
Fuchs, D; Mark, M; Reinhart, WH; Schroecksnadel, K; Walter, RB; Weiss, G1
Freeman, M; Fu, R; Helfand, M; Humphrey, LL; Rogers, K1
Lavie, CJ; Milani, RV1
Bray, P; Cushman, M; Greenland, P; Hendrix, S; Hsia, J; Kooperberg, C; Lloyd-Jones, DM; Pettinger, M; Robinson, J; Rossouw, JE1
Kaptanoğlu, B; Ozdemir, A; Ozdemir, O; Rota, S; Semiz, S1
Nagalla, B; Pitla, S1
Cheng, X; Luo, D; Song, Y; Yan, S1
Chen, MF; Dahhou, M; Dassa, C; Evans, R; Genest, J; Goulet, L; Kahn, SR; Kramer, MS; Lydon, J; McNamara, H; Platt, RW; Rozen, R; Séguin, L1
Chellappa, P; Ramaraj, R1
Md Nurul Jain, J; Prasad Chintakindi, K; Rama Devi Akella, R; Shaik Mohammad, N; Vinukonda, G1
Hoogeveen, EK; Stehouwer, CD2
Givvimani, S; Maldonado, C; Pushpakumar, S; Rosenberger, D; Soni, CV; Todnem, ND; Tyagi, SC; Villafane, J1
Chen, MF; Chien, KL; Hsu, HC; Lee, YT; Su, TC; Sun, Y1
Eshraghian, A; Izadi, HR; Naghshvar, F; Pourahmad, M; Shojaie, M1
Lennie, TA; Son, YJ; Song, EK1
Mitka, M1
Burdan, F; Dworzański, W; Opielak, G1
Aybay, C; Biberoğlu, G; Ezgü, F; Hasanoglu, A; Ozbay, F; Tümer, L1
D'Agostino, R; Jacques, P; O'Donnell, CJ; Pencina, M; Selhub, J; Wilson, PW1
Halilovic, E; Kabil, E1
Drygas, W; Jasiński, B; Kozakiewicz, K; Pajak, A; Posadzy-Małaczyńska, A; Rywik, S; Tykarski, A; Wyrzykowski, B1
Dent, TH1
Didelez, V; Meng, S; Sheehan, NA1
Garg, A1
Clarke, R2
Gong, SJ; Hu, BC; Li, L; Yan, J1
Chen, L; Cheng, X; Hong, K; Hu, J; Liu, L1
Prabhakaran, D; Singh, K1
Agrawal, A; Gupta, BK; Gupta, R; Khatri, M; Panwar, RB; Raja, S; Vaishnav, J1
Flood, VM; Gopinath, B; Mitchell, P; Rochtchina, E; Thiagalingam, A1
Pan, F; Pan, Y; Tian, J; Zhang, Y1
Anand, SS; Assimes, TL; Bennett, DA; Chambers, JC; Clarke, R; Collins, R; Danesh, J; Dötsch-Klerk, M; Elbers, C; Engert, JC; Holm, H; Hopewell, JC; Kleber, ME; Kooner, J; Lathrop, M; Nordestgaard, BG; Ouwehand, WH; Parish, S; Peters, B; Peto, R; Reilly, MM; Saleheen, D; Samani, NJ; Stewart, AF; Tanaka, T; Thorand, B; Verhoef, P; Watkins, H; Xu, P; Yamada, Y; Yusuf, S1
Loscalzo, J; Ueland, PM1
Chen, Y; Huang, T; Li, D; Wahlqvist, ML; Yang, B; Yang, J1
Incampa, S; Jaiyen, S; Khaithong, W; Saokaew, S; Sridetch, S; Sudchada, P1
Gjessing, HK; Igland, J; Nygård, OK; Tell, GS; Ueland, PM; Vollset, SE1
Markovic, D; Ovbiagele, B; Towfighi, A1
Baudin, B; Chalghoum, A; Chkioua, L; Dandana, A; Ferchichi, S; Gammoudi, I; Jeridi, G; Khelil, S; Miled, A; Noichri, Y1
Huang, T; Li, D1
Connelly, PW; Cunnane, SC; Faulkner, D; Jackson, CJ; Jenkins, DJ; Josse, RG; Kendall, CW; Leiter, LA; Parker, T; Vidgen, E1
Kareinen, A; Laakso, M; Lehto, S; Nieminen, MS; Pajunen, P; Syvänne, M; Viitanen, L1
Abdella, N; Akanji, AO; Al Mohammedi, H; Mojiminiyi, OA; Moussa, MA; Zaki, M1
Ashavaid, TF; Dalal, JJ; Eghlim, FF; Nair, KG; Nair, SR1
Andersson, A; Hultberg, B; Jonasson, T; Lindgren, A; Ohlin, H1
Connelly, PW; Faulkner, D; Haight, JS; Jenkins, DJ; Kendall, CW; Lapsley, KG; Marchie, A; Parker, TL; Qian, W; Spiller, GA; Vidgen, E1
Fini, M; Galetta, P; Mercuro, G; Rosano, GM; Rossini, P; Vitale, C1
Bös, U; Pabst, E; Semmelrock, HJ; Stanger, O; Wascher, TC; Wonisch, W1
Elisaf, M1
Robinson, K1
Mehta, JL; Saldeen, TG1
Wnuk, SF1
MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A; Wilcken, D1
McLaughlin, MA; Nguyen, VH1
Ballman, KV; Berger, PB; Brilakis, ES; Klee, GG; McConnell, JP1
Elovaara, I; Jaakkola, O; Janatuinen, T; Jokela, H; Knuuti, J; Laakso, J; Laaksonen, R; Lehtimäki, T; Nuutila, P; Punnonen, K; Raitakari, O; Saikku, P; Salminen, K; Vesalainen, R1
Angelini, GD; Ascione, R; Day, A; Jeremy, JY; Shukla, N; Talpahewa, SP; Wan, IY1
El-Hazmi, MA1
Caldera, A; Dec, GW1
Tonstad, S; Urdal, P1
Blom, HJ; de Graaf, J; den Heijer, M; Stalenhoef, AF; Veerkamp, MJ1
Herrmann, W; Jouma, M; Obeid, R1
Abdella, NA; Akanji, AO; Mojiminiyi, OA; Moussa, MA1
Guo, JX; Wang, X; Zhang, Q1
Blom, HJ; de Bree, A; Kromhout, D; Nadeau, M; Trijbels, FJ; Verschuren, WM1
Blom, HJ; De Bree, A; Kromhout, D; Mennen, LI; Verschuren, WM1
Brnabic, A; MacMahon, S; Neal, B; Ohkubo, T; Tonkin, A1
Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G1
Adler, Y; Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D1
Cheek, DJ; Coffey, M; Crowder, GK1
Haynes, WG1
Elliott, KM1
Law, M; Morris, J; Wald, DS; Wald, NJ1
Handy, DE; Loscalzo, J1
Acevedo, M; Jacobsen, DW; Minor, S; Pearce, GL; Sprecher, DL1
Blom, HJ; den Heijer, M; Klerk, M; Kluijtmans, LA; Kok, FJ; Lievers, KJ; Schouten, EG; Verhoef, P1
Berg, K; Eikvar, L; Retterstol, L1
Baumgartner, RN; Garry, PJ; Lindeman, RD; Romero, LJ; Schade, DS; Wayne, S1
Essebag, V; Genest, J; Pilote, L; Suissa, S1
Chen, C; Conklin, BS; Fu, W; Lin, PH; Lumsden, AB; Yao, Q1
Akdemir, I; Aksoy, M; Aksoy, N; Davutoglu, V; Dinckal, MH; Dinckal, N; Kirilmaz, A; Soydinc, S1
Bruce, IN; Gladman, DD; Ibañez, D; Steiner, G; Urowitz, MB1
Derbeneva, SA; Pogozheva, AV1
Aranda, JL; Díaz-Rubio, P; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez, P; Martínez, J; Núñez, V; Paz, M1
Law, M; Morris, J; Wald, DS1
Doshi, S; Goodfellow, J; Lewis, M; McDowell, I; Moat, S1
Geisel, J; Hennen, B; Herrmann, W; Hübner, U; Knapp, JP1
Clement, L1
Chen, J; Hamm, LL; He, J; Kusek, JW; Muntner, P; Whelton, PK1
Demant, T1
Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Jensen, KR; Muhlestein, JB1
Chambless, LE; Howard, VJ; Malinow, MR; Pettigrew, LC; Sides, EG; Spence, JD; Stampfer, M; Toole, JF; Wang, CH1
Bengtsson, C; Björkelund, C; Landaas, S; Lissner, L; Sundh, V; Thelle, D; Zylberstein, DE1
Huffman, FG; Koutoubi, S2
Adamidis, DN; Boufidou, AI; Gourassas, JT; Karvounis, HI; Kesidis, HT; Louridas, GE; Makedou, AD; Makedou, KG; Papadopoulos, CE; Parharidis, GE1
Beevers, GD; Blann, AD; Felmeden, DC; Lip, GY; Martin, SC; Spencer, CG1
Liebson, PR1
Bisschops, RH; Mali, WP; van der Graaf, Y; van der Grond, J1
Abalain, JH; Lacut, K; Moineau, MP; Mottier, D; Oger, E1
Holubec, L; Mayer, O; Pikner, R; Simon, J; Trefil, L; Vobrubová, I1
Demacker, PN1
Erglis, A; Fuchs, D; Jegere, S; Jurika, E; Kalnins, U; Rudzite, V; Silava, A; Trusinskis, K1
Doshi, SN; Goodfellow, J; Lang, D; Lewis, MJ; McDowell, IF; Moat, SJ1
Börner, C; Dambrink, JH; De Luca, G; Dille, J; Kallmayer, K; Lange, H; Pasalary, MN; Scherer, E; Suryapranata, H1
Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N1
Wilson, PW1
Alfthan, G; Kaplan, GA; Laukkanen, J; Mursu, J; Nyyssönen, K; Rissanen, TH; Salonen, JT; Tuomainen, TP; Valkonen, VP; Virtanen, JK; Voutilainen, S1
Nishio, I; Tsuda, K1
Christodoulou, G; Chrysohoou, C; Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Stefanadis, C; Tsetsekou, E1
Moleerergpoom, W; Sritara, P; Sura, T1
Divitini, ML; Knuiman, MW; O'Leary, CM1
Larson, L; Léger, MM; McNellis, R; Quigley, T; Toth, S; Van Dyke, E1
Abrams, KR; Minelli, C; Thompson, JR; Tobin, MD1
Herer, P; Luboshitzky, R1
Fowler, B; Herrmann, W; Stanger, O1
Roth, E; Szabo, T; Szamosi, T; Tomsits, E; Tordai, A1
Bruckert, E; Jublanc, C1
Dobordzhginidze, LM1
Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rifai, N; Rimm, EB; Shai, I; Stampfer, MJ1
Guo, JX; Hou, LF; Wang, X; Wang, Z; Zhao, YM1
Helenius, H; Juonala, M; Laitinen, T; Marniemi, J; Raitakari, OT; Rönnemaa, T; Viikari, JS1
Cannuscio, C; Curhan, G; Hankinson, SE; Ma, J; Manson, JE; Rimm, EB; Selhub, J; Shai, I; Stampfer, MJ1
Harringer, W; Haverich, A; Kutschka, I; Pethig, K; Strüber, M1
Mao, JM; Wang, G; Wang, X; Zhang, FC1
Lu, H; Sun, J; Xu, Y; Xue, J; Zhu, Y1
Abbate, R; Brunelli, T; Falai, M; Fedi, S; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Margheri, M; Pepe, G; Prisco, D1
Geisel, J; Herrmann, W; Hübner, U; Jouma, M; Obeid, R1
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J1
Magkos, F; Manios, Y; Matalas, AL; Papaconstantinou, E; Papoutsakis, C; Schulpis, KH; Yiannakouris, N; Zampelas, A1
Bodi, V; Chorro, FJ; Fácila, L; G, VB; Llacer, A; Nuñez, JE; Sanchis, J1
Akdemir, R; Arinc, H; Binak, E; Gunduz, H; Ozhan, H; Tamer, A; Uyan, C1
Cesari, M; Pessina, AC; Rossi, GP; Sticchi, D1
Abrams, KR; Minelli, C; Riley, RD; Thompson, JR; Tobin, MD1
Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Lackner, KJ; Lubos, E; Münzel, T; Rupprecht, HJ; Schnabel, R; Tiret, L; Torzewski, M1
Aziz, DC; Blumenthal, RS; Budoff, MJ; Nasir, K; Park, R; Rasouli, ML1
Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE1
Hendrix, SL; LaCroix, AZ; Langer, RD; Lewis, CE; Manson, JE; Pradhan, AD; Ridker, PM; Rossouw, JE1
Abbate, R; Brogi, D; Gensini, GF; Giglioli, C; Gori, AM; Lenti, M; Liotta, AA; Marcucci, R; Prisco, D; Sofi, F; Valente, S1
Favilla, S; Ghiadoni, L; Pinto, S; Salvetti, A; Salvetti, G; Taddei, S; Versari, D; Virdis, A1
Boeing, H; Dierkes, J; Hoffmann, K; Jung, R; Klipstein-Grobusch, K; Schulze, MB; Weikert, C; Windler, E; Zyriax, BC1
Chen, Z; Gao, Y; Hui, R; Liu, Y; Song, L; Wang, J; Xu, H; Yang, X; Yang, Y; Zhen, Y; Zhou, J1
Garcés Pasamontes, A; Morón de Salim, AR1
Chillemi, R; D'Agata, A; Minucci, A; Musumeci, S; Persichilli, S; Simpore, J1
Clarke, R; Lewington, S1
Cesari, M; Pessina, AC; Rossi, GP1
Göller, V1
Ekerbicer, H; Guven, A; Inanc, F; Kilinc, M1
Boran, G; Enright, H; Fitzgerald, A; Fogarty, J; Gaffney, P; Graham, IM; Hanbidge, M; McCarthy, B; Murphy, J; O'Callaghan, PA1
Sakuta, H; Suzuki, T1
Aksoy, Y; Turhan, H; Yetkin, E1
Aksoy, Y; Kosar, F; Ozerol, I; Sincer, I1
Chau, WK; Gau, JP; Ho, CH; Hsu, HC; Kong, CW; Kuo, BI; Yu, YB1
Dowey, le RC; Dunne, A; Hannon-Fletcher, M; Hughes, JP; McAnena, LB; McNulty, H; Molloy, AM; Scott, JM; Strain, JJ; Ward, M1
Alatas, O; Dinleyici, EC; Dogruel, N; Kilic, Z; Kirel, B; Muslumanoglu, H1
Bailey, KR; Bielak, LF; Kardia, SL; Kullo, IJ; Li, G; Peyser, PA; Sheedy, PF; Turner, ST1
Happonen, P; Lakka, TA; Laukkanen, JA; Mursu, J; Poulsen, H; Rissanen, TH; Salonen, JT; Virtanen, JK; Voutilainen, S1
Baumgart, D; Beckert, J; Breuckmann, F; Erbel, R; Haude, M; Naber, C; Schmermund, A1
Abramson, JH; Adler, B; Calderon-Margalit, R; Gofin, J; Kark, JD1
Armstrong, KA; Isbel, NM; Johnson, DW; Leano, R; Marwick, TH; Rakhit, DJ1
Best, JD; Clemens, L; Dragicevic, G; Godfrey, T; Jenkins, AJ; Karschimkus, CS; Lee, AB; Nikpour, M; Prior, DL; Romas, E; Rowley, KG; Wilson, AM1
Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D1
Amouyel, P; Arveiler, D; Ducimetière, P; Evans, A; Ferrières, J; Kee, F; Patterson, CC; Troughton, JA; Woodside, JV; Yarnell, JW; Young, IS1
Elmadfa, I; Genser, D; Halbmayer, WM; Hauer, R; Mlczoch, J; Prachar, H2
Chernikova, IV; Kostiuchenko, GI; Kostiuchenko, LA; Kulikov, VP1
Bolaman, Z; Kadikoylu, G; Ozgel, N; Yenisey, C1
Hajer, GR; Olijhoek, JK; van der Graaf, Y; Verhaar, MC; Visseren, FL1
Dudczak, R; Graf, S; Huber, K; Khorsand, A; Kletter, K; Maurer, G; Nekolla, S; Nikfardjam, M; Ofluoglu, S; Pirich, C1
Cui, RZ; Li, Y; Li, YL; Qin, Q; Wang, H; Zhao, BR; Zhao, FM1
Li, J; Li, JJ; Li, Z1
Bilsel, T; Cakmak, N; Ciloglu, F; Erdem, I; Orhan, L; Peker, I; Sayar, N; Tangurek, B; Terzi, S; Yesilcimen, K; Yilmaz, HY1
Alfthan, G; Erlund, I; Happonen, P; Kaplan, GA; Kauhanen, J; Korhonen, M; Mosher, MJ; Mursu, J; North, KE; Salonen, JT; Tiihonen, J; Tuomainen, TP; Virtanen, JK; Voutilainen, S1
Filipovský, J; Mayer, O; Pikner, R; Plásková, M; Simon, J1
Mair, J1
Boev, M; Doncheva, N; Niagolov, Y; Penkov, A; Popov, B; Velcheva, A1
Adamopoulou, EN; Argyrakis, SK; Beldekos, DJ; Foussas, SG; Handanis, SM; Hatzisavvas, JJ; Makrygiannis, SS; Manolis, AJ; Manousakis, SJ; Melidonis, AI; Patsourakos, NG; Zairis, MN1
Domagała, TB; Jakubowski, H; Mackness, B; Mackness, MI; Trzeciak, WH; Łacinski, M1
Greany, KA; Kurzer, MS; Nettleton, JA; Thomas, W; Wangen, KE1
das Graças Carvalho, M; de Castro Santos, ME; Dusse, LM; Fernandes, AP; Lima, LM; Mota, AP; Ribeiro, DD; Sabino, A; Sousa, MO1
Cui, R; Date, C; Iso, H; Kikuchi, S; Koike, KA; Moriyama, Y; Tamakoshi, A1
Hasić, S; Jadrić, R; Kiseljaković, E; Resić, H; Skenderi, F; Winterhalter-Jadrić, M1
Gupta, VJ; Reddy, SG; Wilcken, DE1
Bostom, AG; Ellison, RC; Jacques, PF; Nadeau, MR; Selhub, J; Williams, RR1
Adão, M; Azinheira, J; Bordalo e Sá, AL; Ferreira, NC; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L; Vilaverde, MM1
Beresford, SA; Boushey, CJ; Motulsky, AG; Omenn, GS1
Becker, PJ; Delport, R; Potgieter, H; Ubbink, JB; van der Merwe, A; Vermaak, WJ1
Graham, IM; Meleady, RA1
Becker, PJ; Delport, R; Ubbink, JB; Vermaak, WJ1
Berwanger, CS; Jeremy, JY; Stansby, G1
Hopkins, PN; Hunt, SC; James, BC; Vincent, GM; Williams, RR; Wu, J; Wu, LL2
Bostom, AG; Eaton, CB; Hume, AL; Jacques, PF; McQuade, W; Nadeau, M; Perrone, G; Selhub, J; Yanek, L1
Dalery, K; Davignon, J; Genest, J; Latour, Y; Lussier-Cacan, S; Selhub, J1
Glueck, CJ; Lang, JE; Shaw, P; Sieve-Smith, L; Tracy, T; Wang, Y1
Malinow, MR2
Ubbink, JB3
Ascherio, A; Willett, WC1
Abdelnoor, M; Arnesen, H; Berg, K; Eritsland, J; Grønseth, K; Malinow, MR; Seljeflot, I1
Ambrosi, P; Barlatier, A; Garcon, D; Habib, G; Kreitman, B; Luccioni, R; Metras, D; Roland, PH; Saingra, S1
Boers, GH1
Assmann, G; Heinrich, J; Köhler, E; Malinow, MR; Schönfeld, R; Schulte, H; Upson, B; von Eckardstein, A1
Acton, RT; Alvarez, JO; Copeland, RB; Cousins, AL; Go, RC; Lewis, CA; Macaluso, M; Pancharuniti, N; Perkins, LL; Sauberlich, HE1
Alderman, EL; Murphy-Chutorian, D1
Daly, L; Graham, IM; Robinson, K; Tan, KS1
Bostom, AG; Catalfamo, J; Eaton, CB; McQuade, W; Selhub, J; Yanek, L1
Dudman, NP; Lundberg, P; Lynch, JF; Macey, D; Wang, J; Wilcken, DE1
Bierdrager, E; Rauwerda, JA; Stehouwer, CD; van den Berg, M1
Arnesen, E; Bønaa, KH; Førde, OH; Nordrehaug, JE; Refsum, H; Ueland, PM1
Motulsky, AG1
Drown, DJ1
Angst, CP; Fowler, B; Haefeli, WE; Jordan, PP; Loehrer, FM; Ritz, R1
Delport, R; Ubbink, JB; Vermaak, WJ1
Allen, RH; Herzlich, BC; Lichstein, E; Malinow, MR; Namba, T; Nieto, FJ; Pagala, M; Ravindran, K; Schulhoff, N; Stabler, SP; Weinstock, M1
Adao, M; Azinheira, J; Bordalo, A; Ferreira, NC; Luis, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L1
Racek, J; Rosolová, H; Simon, J1
Sobra, J1
Aull, S; Deecke, L; Lalouschek, W; Schnider, P; Uhl, F; Zeiler, K1
Montalescot, G1
Fleischer, L; Handler, B; Kummerow, FA; Olinescu, R1
Arveiler, D; Cambien, F; Ducimetiere, P; Evans, AE; Luc, G; Malinow, MR; Upson, BM1
Evans, A; Gallagher, PM; Graham, IM; McMaster, D; Meleady, R; Rozen, R; Shields, DC; Tan, KS; Whitehead, AS1
Superko, HR2
Bignell, M; Hanson, NQ; Schwichtenberg, K; Tsai, MY1
Pilgeram, L1
Perry, IJ1
Ankri, A; Benzidia, R; Blacher, J; Chadefaux-Vekemans, B; Grosgogeat, Y; Kamoun, P; Montalescot, G; Thomas, D1
Cheng, TO6
Sanderson, JE; Sung, JJ1
Mamotte, CD; Taylor, RR; van Bockxmeer, FM; Vasikaran, SD1
Adão, M; Azinheira, J; Bordalo-Sá, AL; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP; Santos, L1
Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM1
Allain, P; Benoit, C; Geslin, P; Le Bouil, A; Olivier, E; Tadei, A1
Christensen, B; Frosst, P; Genest, J; Goyette, P; Lussier-Cacan, S; Rosenblatt, DS; Rozen, R; Selhub, J1
Futterman, LG; Lemberg, L1
Aizawa, T; Kaneda, H; Kitaoka, M; Kurihara, H; Kurihara, Y; Maemura, K; Minamino, T; Morita, H; Ogasawara, K; Ohno, M; Shindo, T; Suzuki, S; Taguchi, J; Yamaoki, K; Yazaki, Y2
Mansoor, MA1
Anderson, PH; Block, PC; Duell, PB; Gluckman, RA; Hess, DL; Holzgang, CR; Kruger, WD; Lin, QR; Malinow, MR; Nieto, FJ; Seltzer, D; Upson, B1
Farstad, M; Nordrehaug, JE; Nygård, O; Refsum, H; Ueland, PM; Vollset, SE1
Conri, C; Gosse, P; Le Metayer, P; Mercié, P; Parrot, F1
DeRose, DJ; Mullen, K; Muscat, J1
Aljada, A; Baliga, BS; Dandona, P; Fink, L; Fonseca, VA; Munshi, M; Stone, A; Thusu, K1
Donner, MG; Richter, WO; Schwandt, P1
Bjerve, KS; Carlsen, SM; Følling, I; Grill, V; Refsum, H; Schneede, J1
Markle, HV1
Blom, HJ; Boerma, GJ; Boers, GH; Bruschke, AV; Heil, SG; Jukema, JW; Kastelein, JJ; Kluijtmans, LA; Lindemans, J; Trijbels, FJ; van den Heuvel, LP; Verheugt, FW; Willems, F1
Wang, XL; Wilcken, B; Wilcken, DE1
Ahn, C; Aronow, WS2
Bottiglieri, T; Lowenthal, D; Parnetti, L1
Frohlich, JJ; McManus, BM; Moghadasian, MH1
Baudouy, M; Candito, M; Gibelin, P; Houenassi, M; Morand, P; Van Obberghen, E1
Hopkins, PN; Hunt, SC; James, BC; Vincent, GM; Williams, RR; Wu, LL1
Moll, S1
Farhadi, D1
Assmann, G; von Eckardstein, A1
Mendall, MA; Perry, IJ; Strachan, DP; Whincup, PH1
Markus, H; Mendall, ME; Saxena, V; Swaminathan, S1
Chook, P; Sanderson, JE; Woo, KS; Young, RP1
Beresford, SA; Motulsky, AG; Omenn, GS1
Arheart, K; Boers, G; Brattström, L; Daly, L; Graham, I; Meleady, R; Palma-Reis, R; Refsum, H; Robinson, K; Rubba, P; Ueland, P; Witteman, J1
Donner, MG; Klein, GK; Mathes, PB; Richter, WO; Schwandt, P1
Rimm, EB; Stampfer, MJ; Verhoef, P1
Anderson, PH; Block, PC; Duell, PB; Gluckman, RA; Hess, DL; Kruger, WD; Malinow, MR; Phillipson, BE; Upson, BM1
Amemiya, H; Arinami, T; Fujiwara, H; Hamaguchi, H; Kawata, K; Kikuchi, S; Noguchi, Y; Ou, T; Saito, M; Sugishita, Y; Yamakawa-Kobayashi, K1
Abbate, R; Brunelli, T; Capanni, M; Fatini, C; Gensini, GF; Marcucci, R; Pepe, G; Prisco, D; Sardi, I; Simonetti, I1
Bata, I; Dempsey, G; Dunn, J; Johnstone, DE; Kirkland, SA; MacDonald, MC; Nassar, B; O'Neill, BJ; Title, LM; Zayed, E1
Brönstrup, A; Pietrzik, K1
Ambrosi, P; Barlatier, A; Bouvenot, G; Garçon, D; Habib, G; Kreitmann, B; Luccioni, R; Métras, D; Riberi, A; Rolland, PH1
Davis, CE; Eckfeldt, JH; Folsom, AR; Hess, DL; Malinow, MR; McGovern, PG; Nieto, FJ; Tsai, MY1
Bloomgarden, ZT1
Chen, J; Hunter, DJ; Kelsey, K; Rimm, EB; Stampfer, MJ; Verhoef, P; Willett, WC1
Bissé, E; Dierkes, J; Luley, C; Mayer, H; Nauck, M; Orth, M; Wieland, H1
Franco, A; Haverstick, L; Malone, M; Rothkopf, MM; Usiskin, K1
Wanner, C; Zimmermann, J1
Czeizel, E; Matos, L1
Connor, SL; Connor, WE; Gerhard, GT; Malinow, MR; Pappu, AS; Sexton, G; Wander, RC1
Mijatovic, V; Stehouwer, CD; van Baal, WM; van der Mooren, MJ1
Feskens, EJ; Jakobs, C; Kromhout, D; Stehouwer, CD; van den Berg, M; Weijenberg, MP1
Ali, A; Lavie, CJ; Li, S; Lin, HC; Lohmann, TP; Malik, FS; Mehra, MR; Milani, RV; Murgo, JP1
Daida, H; Hosoda, Y; Iwama, Y; Mokuno, H; Yamaguchi, H; Yokoi, H1
Danesh, J; Lewington, S1
Asmi, M; Busjahn, A; Joubran, R; Jouma, M; Luft, FC; Vergopoulos, A1
de Lorgeril, M; Lacan, P; Paillard, F; Richard, G; Salen, P1
Hamada, C; Kurihara, H; Kurihara, Y; Morita, H; Oh-hashi, Y; Shindo, T; Sugiyama, T; Yazaki, Y1
Bayle, C; Bellet, H; Caussé, E; Champagne, S; Couderc, F; Salvayre, R; Siri, N; Valdiguié, P1
Kluger, J1
Abou-Ghazala, T; Alsous, F; Arheart, K; Gupta, A; Jacobsen, DW; Kruger, WD; Lobo, A; Moustapha, A; Nahlawi, M; Naso, A; Robinson, K; van Lente, F1
McNamara, JR; Schaefer, EJ; Seman, LJ1
Carluccio, M; De Caterina, R; Diviacco, S; Fioretti, P; Mariani, M; Pilotto, L; Quadrifoglio, F; Vanuzzo, D1
Bignell, MK; Bullemer, FE; Graham, KJ; Hanson, NQ; Rasmussen, R; Schwichtenberg, K; Tsai, MY; Vessey, J; Welge, BG; Yang, F1
Alikaşifoğlu, M; Atalar, E; Aytemir, K; Kes, S; Ovünç, K; Ozer, N; Tokgözoğlu, SL; Tunçbilek, E; Usal, O1
Berenson, GS; Dalferes, E; Greenlund, KJ; Myers, L; Pickoff, A; Srinivasan, SR; Xu, JH1
Abel, JG; Cook, RC; Frohlich, JJ; Gao, M; Ignaszewski, AP; Kingsbury, K; Parker, S; Tupper, JK1
Assmann, G; Bobak, M; Bui, M; Fobker, M; Gostomzyk, J; Hense, HW; Junker, R; Kark, J; Kuch, B; Marmot, M; Schulte, H; Sinnreich, R; Vojtisek, P; von Eckardstein, A1
Connor, SL; Connor, WE; DeLoughery, TG; Evans, AJ; Gerhard, GT; Malinow, MR; Sexton, G; Wander, RC1
Beaulieu, AJ; Bostom, AG; Dworkin, L; Gohh, RY; Han, H; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J1
Bausserman, L; Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J1
Illingworth, DR1
Adachi, T; Cai, H; Cranney, G; Duarte, N; Sim, AS; Wang, XL; Wilcken, DE1
Ebrahim, SB; Lennon, L; Morris, R; Perry, IJ; Refsum, H; Thomson, A; Ueland, PM; Walker, M; Whincup, PH1
Britten, MB; Elsner, M; Schächinger, V; Scharrer, I; Walter, DH; Zeiher, AM1
Cole, DE; Langman, LJ1
Keller, C; Pietrzik, K; Weiss, N1
Haraki, T; Inazu, A; Kajinami, K; Kawashiri, M; Koizumi, J; Mabuchi, H; Nohara, A; Takegoshi, T; Yagi, K1
Aranda, JL; Díaz-Rubio, P; Estenoz, J; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez González, P1
Daniels, SR; Jacobsen, DW; Khoury, P; Morrison, JA; Robinson, K; Sprecher, DL1
Allain, P; Benoit, C; Furber, A; Geslin, P; Le Bouil, A; Merheb, M; Tadéi, A1
Cattaneo, M3
Ridker, PM1
Dudman, NP1
Tsai, MY1
Hughes, S1
McCarron, P; Smith, GD; Stone, DH1
Asmi, M; Joubran, R; Jouma, M; Law, T; Rifai, N; Spencer, A; Yu, HH1
Foody, JM; Jacobsen, DW; Milberg, JA; Pearce, GL; Robinson, K; Sprecher, DL1
Chambers, JC; Hackett, D; Hooper, J; Kooner, JS; Obeid, OA; Refsum, H; Thompson, SG; Turner, RM; Ueland, P1
Park, SC; Yoo, JH1
Bar-On, H; Ben-Yehuda, A; Friedlander, Y; Friedman, G; Kidron, M; Rosenberg, IH; Selhub, J1
Hughes, K; Ong, CN1
Bunout, D; de la Maza, P; Garrido, A; Hirsch, S; Kauffman, R; Petermann, M; Suazo, M; Venegas, P1
Bignell, M; Graham, KJ; Hanson, NQ; Tsai, MY; Welge, BG; Yang, F1
Araújo, F; Cunha-Ribeiro, LM; Gonçalves, L; Lopes, M; Maciel, MJ1
Mann, GV1
Cipriano, C; Conri, C; Constans, J; Parrot, F; Skopinski, S1
Alagratnam, D; Swaminathan, R; Turner, C; Wickramasinghe, SN; Wierzbicki, AS1
Hallegua, DS; Wallace, DJ1
Apple, FS; DiBello, PM; Holtman, V; Jacobsen, D; Ricchiuti, V; Wu, AH1
Abdelmouttaleb, I; Aimone-Gastin, I; Angioi, M; Bennani, N; Danchin, N; Gelot, MA; Guéant, JL; Jeandel, C; Lambert, D; Namour, F1
Kaplan, GA; Lakka, TA; Porkkala-Sarataho, E; Rissanen, T; Salonen, JT; Voutilainen, S1
Herzum, M; Maisch, B; Noll, B; Sattler, A; Schaefer, JR; Simon, B; Soufi, M1
Anderson, PH; Block, PC; Duell, PB; Evans, AA; Graf, EE; Hess, DL; Kruger, WD; Malinow, MR; Upson, B; Wang, L1
Bhuripunyo, K; Leowattana, W; Mahanonda, N; Pokum, S1
Calzoni, F; Carantoni, M; D'Elia, K; Fellin, R; Pareschi, PL; Passaro, A; Solini, A1
Barrera, G; Bunout, D; de la Maza, P; Hirsch, S; Kauffman, R; Petermann, M; Suazo, M1
Caidahl, K; Christensen, B; Hartford, M; Herlitz, J; Karlsson, T; Omland, T; Samuelsson, A1
Gejyo, F; Hiraoka, M; Kimura, H; Kobata, R; Mayumi, M; Nishida, K; Saito, M; Toyooka, M; Tsuchida, S; Tsukahara, H1
Brattström, L1
Baker, H; Falanagan, P; McGonigle, N; Swaney, C1
Bernhard, W; Fuchs, D; Ledochowski, M1
Raheja, BS; Talim, M1
Ghosh, P; Khan, SA1
Swaminathan, R; Wierzbicki, AS1
Booth, GL; Wang, EE1
Brattström, L; Hultberg, B; Landgren, F; Nielsen, NE; Swahn, E1
Arnett, DK; Eckfeldt, JH; Ellison, RC; Tsai, MY; Williams, RR1
Babaei, S; Banijamali, H; Bowman, KA; Chisholm, RJ; Connelly, PW; Hegele, RA; Lau, HK; Miner, SE; Sparkes, J; Strauss, BH; Teitel, JM1
Hamada, C; Kitaoka, M; Kurihara, H; Kuwaki, T; Morita, H; Nagai, R; Suzuki, S; Yazaki, Y1
Hämelahti, P; Lakka, TA; Lehtimäki, T; Poulsen, HE; Salonen, JT; Voutilainen, S1
Borkenstein, M; Erwa, W; Gallistl, S; Mangge, H; Sudi, K1
Allen, JK; Blumenthal, aR; Nass, CM; Post, WS; Wiviott, SD1
Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Madsen, TE; Muhlestein, JB; Pearson, RR1
Cummings, PM; Genest, JJ; Giddens, K; Nassar, BA; Title, LM1
Brown, CA; Gravel, RA; Kaufman, JS; McKinney, KQ; Rozen, R1
Misra, A1
Assmann, G; Cullen, P1
Gao, W; Jiang, N; Zhu, G1
Cleophas, TJ; Hornstra, N; van der Meulen, J; van Hoogstraten, B1
Chambers, JC; Ireland, H; Kooner, JS; Lane, DA; Obeid, OA; Refsum, H; Reilly, P; Thompson, E; Ueland, P1
Arcelus, R; Blanco-Vaca, F; Camps, J; Figuera, L; Joven, J; Martorell, L; Simó, JM; Vilella, E; Virgos, C1
Chambers, JC; Kooner, JS; Obeid, OA; Refsum, H; Ueland, PM; Wrigley, J1
Landmark, K; Reikvam, A1
Graham, IM; O'Callaghan, P1
Abdella, N; Akanji, AO; Mojiminiyi, OA1
Evans, M; Oudit, GY; Taylor, BV1
Aras, O; Hanson, NQ; Tsai, MY; Yang, F1
Crook, MA; Junadi, E; Lambert-Hammill, M; Lumb, PJ; Wierzbicki, AS1
Ben-Shlomo, Y; Elwood, P; Fallon, UB; Smith, GD; Ubbink, JB1
Balcells, S; Ferrer, I; Garcia-Giralt, N; Grinberg, D; Mainou, C; Meco, JF; Ordovás, JM; Palá, M; Pintó, X; Vilaseca, MA1
Ayaori, M; Higashi, K; Hisada, T; Ishikawa, T; Ito, T; Nakajima, K; Nakamura, H; Ohsuzu, F; Saionji, K; Shige, H; Tamai, S; Yonemura, A; Yoshida, H1
Hanson, NQ; Schwichtenberg, K; Tsai, MY; Yang, F1
Maxwell, SR1
Abrams, J; Chai, AU1
Assanelli, D1
Vos, E1
Akyürek, O; Dinçer, I; Erol, C; Ertas, F; Gülec, S; Kiliçkap, M; Kumbasar, SD; Laleli, Y; Oral, D; Sipahi, E1
Baumann, G; Cascorbi, I; Gerloff, T; Laule, M; Meisel, C; Müller, JM; Roots, I; Stangl, K; Stangl, V; Wernecke, KD1
Choi, TM; Hong, SY; Hwang, KY; Kim, CH; Shin, WY1
Aras , O; Hanson, NQ; Tsai, MY; Yang, F1
Chou, ST; Huang, JL; Ko, LE; Lim, PS; Yang, CS1
Crooks, RL; Fryer, JL; Silberberg, JS; Wlodarczyk, JH1
Axenti, I; Brzostek, T; Czachór, R; Dropiński, J; Jankowski, M; Musiał, J; Sanak, M; Szczeklik, A; Tendera, M; Twardowska, M1
Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J1
Alfthan, G; Aromaa, A; Heliövaara, M; Knekt, P; Marniemi, J; Reunanen, A; Rissanen, H2
Armani, U; Bertolini, S; Cerone, R; Minniti, G; Piana, A; Susco, G1
Jones, HJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC1
Lavie, L; Levy, Y; Yeromenko, Y1
Doshi, SN; Goodfellow, J; Kredan, MB; Lang, D; Lewis, MJ; McDowell, IF; Moat, SJ; Newcombe, RG1
Alho, H; Jokela, H; Kalela, A; Koivu, TA; Koivula, T; Nikkari, ST; Sillanaukee, P1
Chambers, JC; Kooner, JS1
Hecht, HS; Superko, HR1
D'Agostino, RB; Jacques, PF; Meigs, JB; Nathan, DM; Rifai, N; Selhub, J; Singer, DE; Wilson, PW1
Atzmon, O; Baruch, Y; Ben-Ari, Z; Fainaru, M; Greenberg, A; Levi, N; Schafer, Z; Sulkes, J; Tur-Kaspa, R1
Baigent, C; Jones, HJ; Kendall, MJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC1
Cincotta, M; O'Dea, K; Pindan, B; Rowley, KG; Skinner, K; Skinner, M; Su, Q; White, GA1
Aksoyek, S; Haznedaroglu, I; Kabakci, G; Kes, S; Kirazli, S; Oto, A; Ovunc, K; Ozmen, F; Sinici, I; Tokgozoglu, SL; Yildirir, A1
Gao, W; Jiang, N; Meng, Z; Tang, J1
Alimollah, A; Gao, SZ; Giannetti, N; Herity, NA; Hunt, SA; Schroeder, JS; Valantine, HA; Yeung, AC1
Cole, DE; Daly, PA; Evrovski, J; Miner, SE; Ross, HJ; Verma, A1
Chen, Z; Tang, J; Xu, H1
Jang, Y; Kim, OY; Lee, JH; Lee, SY; Park, HY1
Chen, J; Gao, R; Hui, R; Liu, H; Wu, Y; Zhang, C1
Bushara, K; Bushara, M; Fiore, MC; Jorenby, DE; McBride, PE; Stein, JH1
Adlercreutz, H; Kaikkonen, J; Morrow, JD; Nurmi, T; Roberts, LJ; Salonen, JT; Vanharanta, M; Voutilainen, S1
Erkelens, DW; Roeters van Lennep, JE; van der Wall, EE; Westerveld, HT1
Acevedo, M; Cross, JA; Foody, JM; Frolkis, JP; Hoogwerf, BJ; Pashkow, FJ; Pearce, GL; Robinson, K; Sprecher, DL; Vidt, DG1
Ozkan, E; Ozkan, Y; Simşek, B1
Ford, ES; Mueller, PW; Smith, SJ; Steinberg, KK; Stroup, DF; Thacker, SB1
Bickel, C; Blankenberg, S; Hofman, KP; Meyer, J; Peetz, D; Rupprecht, HJ; Tiret, L1
Andersson, A; Arnadottir, M; Hultberg, B; Jonasson, T; Ohlin, H1
Al-Attas, O; Al-Daghri, N; Al-Maatouq, M; Al-Nozah, M; Bartlett, WA; Jones, AF; Kumar, S; Martin, SC1
Bode, G; Brenner, H; Fischer, HG; Hoffmann, MM; Hoffmeister, A; Koenig, W; März, W; Rosenthal, J; Rothenbacher, D1
Battler, A; Birnbaum, Y; Magal, N; Mager, A; Shohat, M1
Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE1
Kobayashi, K; Kouzuma, R; Miyamoto, M; Nagai, Y; Nakashima, Y; Nihei, S; Okazaki, M; Tasaki, H; Tsutsui, M; Yamashita, K1
Abreu González, P; Domínguez Rodríguez, A; Jiménez Sosa, A1
Green, R; Jagust, WJ; Miller, JW; Mungas, DM; Reed, BR1
Burke, V; Kaye, JM; McCann, VJ; Stanton, KG; Taylor, RR; van Bockxmeer, FM; Vasikaran, SD1
Jacques, PF; Kark, JD; Rosenberg, IH; Selhub, J; Sinnreich, R1
Acampa, M; Capecchi, PL; Cuomo, A; Diciolla, F; Giordano, A; Guideri, F; Laghi Pasini, F; Lazzerini, PE; Lisi, GF; Maccherini, M; Massai, MR; Toscano, M1
Knopp, RH1
Abreu González, P; Barragán Acea, A; de Armas Trujillo, D; Domínguez Rodríguez, A; García González, MJ; Jiménez Sosa, A1
Costimba, I; Delaportas, N; Georgalidis, C; Kaliolia, I; Karaliotas, G; Katsarou, A; Klonou, E; Koulouridis, E; Krokida, A; Lachanas, A; Panagiotaki, E; Tzilianos, M1
Fendrick, AM; Nallamothu, BK; Omenn, GS1
Wilcken, B; Wilcken, DE1
Berg, K1
Lewis, CA; Pancharuniti, N; Sauberlich, HE1
Berg, K; Kierulf, P; Malinow, MR; Upson, B1
Hennekens, CH; Malinow, MR; Newcomer, LM; Stampfer, MJ; Tishler, PV; Ullmann, D; Upson, B; Willett, WC1
Olszewski, AJ1
Becker, PJ; Bennett, JM; Bissbort, S; Ubbink, JB; van Staden, DA; Vermaak, WJ1
Kang, SS; Norusis, M; Ruggie, N; Sora, J; Susmano, A; Wong, PW1
Cahalane, S; Clarke, R; Daly, L; Fowler, B; Graham, I; Naughten, E; Robinson, K1
Genest, JJ; Malinow, MR; McNamara, JR; Salem, DN; Schaefer, EJ; Wilson, PW1
McCully, KS; Olszewski, AJ; Szostak, WB1
Bialkowska, M; McCully, KS; Olszewski, AJ; Rudnicki, S; Szostak, WB1
Borst, M; Deussen, A; Kroll, K; Schrader, J1
Cook, HY; Kang, SS; Messer, JV; Norusis, M; Wong, PW1
Achterberg, PW; de Jong, JW; de Tombe, PP; Harmsen, E1

Reviews

86 review(s) available for homocysteine and Coronary Disease

ArticleYear
The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
    Heart (British Cardiac Society), 2013, Volume: 99, Issue:23

    Topics: Aged; Angina, Unstable; Biomarkers; Case-Control Studies; Coronary Disease; Female; Genotype; Heterozygote; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors

2013
Novel metabolic biomarkers of cardiovascular disease.
    Nature reviews. Endocrinology, 2014, Volume: 10, Issue:11

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adiponectin; Biomarkers; Coronary Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glycated Hemoglobin; Haptoglobins; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Vitamin D

2014
An alternative pseudolikelihood method for multivariate random-effects meta-analysis.
    Statistics in medicine, 2015, Feb-10, Volume: 34, Issue:3

    Topics: Aryldialkylphosphatase; Computer Simulation; Coronary Disease; Homocysteine; Humans; Likelihood Functions; Male; Methylenetetrahydrofolate Reductase (NADPH2); Models, Statistical; Multivariate Analysis; Prostatic Neoplasms

2015
Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
    Journal of Zhejiang University. Science. B, 2015, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Observational Studies as Topic; Odds Ratio; Prospective Studies; Young Adult

2015
Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:11

    Topics: Adult; Case-Control Studies; Cohort Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Odds Ratio; Prospective Studies; Risk Factors; Sex Factors

2008
Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms.
    Current vascular pharmacology, 2010, Volume: 8, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Calcium Signaling; Connexins; Coronary Disease; Death, Sudden, Cardiac; Dietary Supplements; Heart; Heart Conduction System; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinases; Myocardium; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Risk Factors; Vitamin B Complex

2010
Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction.
    Atherosclerosis, 2010, Volume: 213, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Apolipoprotein A-I; Apolipoproteins B; Apolipoproteins E; Biomarkers; C-Reactive Protein; Coronary Disease; Cystatin C; Fibrinogen; Homocysteine; Humans; Lipoproteins; Natriuretic Peptide, Brain; Risk; Risk Assessment; Risk Factors; Uric Acid

2010
Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies.
    DNA and cell biology, 2012, Volume: 31, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Algorithms; Case-Control Studies; Coronary Disease; Ferredoxin-NADP Reductase; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Metabolic Networks and Pathways; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Review Literature as Topic; Risk Factors; White People

2012
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
    PLoS medicine, 2012, Volume: 9, Issue:2

    Topics: Bias; Coronary Disease; Folic Acid; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors

2012
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
    Clinical nutrition (Edinburgh, Scotland), 2012, Volume: 31, Issue:4

    Topics: Coronary Disease; Databases, Factual; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex

2012
Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.
    Diabetes research and clinical practice, 2012, Volume: 98, Issue:1

    Topics: Aged; Blood Glucose; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin B Complex

2012
How progestins influence the cardiovascular effect of hormone replacement therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2001, Volume: 15 Suppl 6

    Topics: Animals; Blood Glucose; Cardiovascular Diseases; Cardiovascular System; Coronary Disease; Estrogen Replacement Therapy; Female; Hemostasis; Homocysteine; Humans; Insulin; Lipids; Menopause; Progestins; Risk Factors

2001
Effects of fibrates on serum metabolic parameters.
    Current medical research and opinion, 2002, Volume: 18, Issue:5

    Topics: Anticholesteremic Agents; Carbohydrates; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Lipoproteins; Liver; Triglycerides; Uric Acid

2002
Dietary modulations in the prevention of coronary artery disease: a special emphasis on vitamins and fish oil.
    Current opinion in cardiology, 2002, Volume: 17, Issue:5

    Topics: alpha-Tocopherol; Animals; Antioxidants; Coronary Disease; Dietary Supplements; Fatty Acids, Unsaturated; Fish Oils; Homocysteine; Humans; Superoxide Dismutase; Vitamins

2002
Targeting "hydrolytic" activity of the S-adenosyl-L-homocysteine hydrolase.
    Mini reviews in medicinal chemistry, 2001, Volume: 1, Issue:3

    Topics: Adenosine; Adenosylhomocysteinase; Coronary Disease; Drug Design; Enzyme Inhibitors; Homocysteine; Humans; Hydrolases; Hydrolysis; Risk Factors; Structure-Activity Relationship

2001
Coronary artery disease in women: a review of emerging cardiovascular risk factors.
    The Mount Sinai journal of medicine, New York, 2002, Volume: 69, Issue:5

    Topics: Anticholesteremic Agents; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Oxidative Stress; Risk Factors; Thrombophilia; Women's Health

2002
Hematological risk factors for coronary heart disease.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2002, Volume: 11 Suppl 2

    Topics: Antithrombins; Bacterial Infections; Coronary Disease; Factor V; Factor VIII; Fibrinogen; Homocysteine; Humans; Mutation; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Prothrombin; Risk Factors

2002
Hyperhomocysteinemia and transplant coronary artery disease.
    Transplantation, 2002, Nov-27, Volume: 74, Issue:10

    Topics: Animals; Coronary Disease; Folic Acid; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Pyridoxine

2002
[Helicobacterium pylori infection and coronary heart disease].
    Sheng li ke xue jin zhan [Progress in physiology], 1999, Volume: 30, Issue:1

    Topics: Animals; Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans

1999
Reducing coronary artery disease by decreasing homocysteine levels.
    Critical care nurse, 2003, Volume: 23, Issue:1

    Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Nurse's Role; Patient Education as Topic; Primary Prevention; Risk Factors; Vitamin B 12; Vitamin B 6

2003
Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5

    Topics: Arteriosclerosis; Avitaminosis; Coronary Disease; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Failure, Chronic; Methionine; Risk Factors; Thrombosis; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency; Vitamins

2002
Homocysteine and atherothrombosis: diagnosis and treatment.
    Current atherosclerosis reports, 2003, Volume: 5, Issue:4

    Topics: Arteriosclerosis; Coronary Disease; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Oxidative Stress; Polymorphism, Genetic; Thrombosis

2003
The nested case-control study in cardiology.
    American heart journal, 2003, Volume: 146, Issue:4

    Topics: Biomarkers; Cardiology; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Meta-Analysis as Topic; Prospective Studies; Risk Factors

2003
[Homocysteine as a coronary risk factor].
    Voprosy pitaniia, 2003, Volume: 72, Issue:5

    Topics: Alcoholic Beverages; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diet; Female; Folic Acid; Glycine max; Homocysteine; Humans; Hyperhomocysteinemia; Male; Platelet Aggregation; Risk Factors; Vitamin B 12; Vitamin B 6

2003
Serum homocysteine and the severity of coronary artery disease.
    Thrombosis research, 2003, Volume: 111, Issue:1-2

    Topics: Biomarkers; Coronary Disease; Coronary Vessels; Homocysteine; Humans

2003
[Emerging risk factors for cardiovascular disease].
    Deutsche medizinische Wochenschrift (1946), 2004, Jan-30, Volume: 129, Issue:5

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Risk Factors

2004
Assessment of risk factors for coronary heart disease in vascular medicine: long-term experience and a personal view from the laboratory.
    Seminars in vascular medicine, 2004, Volume: 4, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Laboratories; Risk Assessment; Risk Factors

2004
Treatment of coronary heart disease with folic acid: is there a future?
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:1

    Topics: Coronary Disease; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Inflammation

2004
Assessing coronary heart disease risk with traditional and novel risk factors.
    Clinical cardiology, 2004, Volume: 27, Issue:6 Suppl 3

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Lipoprotein(a); Risk Assessment; Risk Factors

2004
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Kardiologiia, 2004, Volume: 44, Issue:3

    Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides

2004
Is homocysteine important as risk factor for coronary heart disease?
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2005, Volume: 15, Issue:2

    Topics: Aging; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prospective Studies; Risk Factors; Sex Characteristics

2005
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
    Current pharmaceutical design, 2005, Volume: 11, Issue:17

    Topics: Clinical Trials as Topic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Meta-Analysis as Topic; Predictive Value of Tests; Risk Factors

2005
Homocysteine-lowering trials for prevention of heart disease and stroke.
    Seminars in vascular medicine, 2005, Volume: 5, Issue:2

    Topics: Biomarkers; Clinical Trials as Topic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Stroke; Treatment Outcome; Vitamin B Complex

2005
Homocysteine and coronary heart disease.
    Seminars in vascular medicine, 2002, Volume: 2, Issue:4

    Topics: Adult; Child; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Stroke; Vitamin B Complex; Vitamins

2002
Homocysteine-lowering treatment in coronary heart disease.
    Current medicinal chemistry. Cardiovascular and hematological agents, 2005, Volume: 3, Issue:4

    Topics: Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Vitamins

2005
[Biomarkers in cardiology--state of the art 2007].
    Wiener medizinische Wochenschrift (1946), 2007, Volume: 157, Issue:3-4

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Heart Diseases; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin

2007
Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases.
    Bosnian journal of basic medical sciences, 2008, Volume: 8, Issue:2

    Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Kidney; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Models, Genetic; Neoplasms; Neurodegenerative Diseases; Pharmacogenetics; Polymorphism, Genetic; Risk; Risk Factors

2008
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.
    JAMA, 1995, Oct-04, Volume: 274, Issue:13

    Topics: Arteriosclerosis; Coronary Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Pyridoxine; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency

1995
Homocysteine as a risk factor for coronary artery disease.
    Journal of cardiovascular risk, 1995, Volume: 2, Issue:3

    Topics: Coronary Disease; Homocysteine; Humans; Nutritional Physiological Phenomena; Risk Factors

1995
Homocysteine and vascular disease.
    The British journal of surgery, 1995, Volume: 82, Issue:6

    Topics: Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Peripheral Vascular Diseases; Thrombophlebitis; Vascular Diseases

1995
Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.
    Clinical chemistry, 1995, Volume: 41, Issue:1

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans

1995
Vitamin nutrition status and homocysteine: an atherogenic risk factor.
    Nutrition reviews, 1994, Volume: 52, Issue:11

    Topics: Arteriosclerosis; Case-Control Studies; Coronary Disease; Folic Acid; Homocysteine; Humans; Nutritional Status; Pyridoxine; Risk Factors; Vitamin B 12

1994
New directions in dietary studies of coronary heart disease.
    The Journal of nutrition, 1995, Volume: 125, Issue:3 Suppl

    Topics: Coronary Disease; Diet; Dietary Fats; Dietary Fiber; Homocysteine; Humans; Iron; Risk Factors; Vitamins

1995
Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    The Netherlands journal of medicine, 1994, Volume: 45, Issue:1

    Topics: Arteriosclerosis; Betaine; Coronary Disease; Folic Acid; Heterozygote; Homocysteine; Homocystinuria; Homozygote; Humans; Methionine; Pyridoxine; Risk Factors; Vascular Diseases

1994
Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid.
    American journal of human genetics, 1996, Volume: 58, Issue:1

    Topics: Arteriosclerosis; Coronary Disease; Female; Folic Acid; Homocysteine; Homocystinuria; Humans; Male; Neural Tube Defects; Nutritional Physiological Phenomena; Polymorphism, Genetic; Risk Factors; Sex Characteristics

1996
Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
    The Journal of nutrition, 1996, Volume: 126, Issue:4 Suppl

    Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Risk Factors

1996
Homocysteine--an atherogenic and a thrombogenic factor?
    Nutrition reviews, 1995, Volume: 53, Issue:11

    Topics: Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors; Thrombophlebitis

1995
[Hyperhomocysteinemia].
    Casopis lekaru ceskych, 1996, May-02, Volume: 135, Issue:9

    Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Neural Tube Defects

1996
[Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Fortschritte der Neurologie-Psychiatrie, 1996, Volume: 64, Issue:7

    Topics: Amino Acid Metabolism, Inborn Errors; Arterial Occlusive Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Homocystine; Humans; Risk Factors

1996
Lipid disorders contributing to coronary heart disease: an update.
    Current problems in cardiology, 1996, Volume: 21, Issue:11

    Topics: Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Risk

1996
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
    Biochemical Society transactions, 1997, Volume: 25, Issue:1

    Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Coronary Disease; Estrogen Antagonists; Female; Homocysteine; Humans; Male; Myocardial Infarction; Tamoxifen

1997
[Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?].
    Fortschritte der Medizin, 1997, Jul-20, Volume: 115, Issue:20-21

    Topics: Adult; Child; Coronary Disease; Genetic Carrier Screening; Homocysteine; Homocystinuria; Humans; Risk Factors

1997
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
    Circulation, 1997, Oct-21, Volume: 96, Issue:8

    Topics: Coronary Disease; Enzyme Stability; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Temperature

1997
Role of homocysteine in age-related vascular and non-vascular diseases.
    Aging (Milan, Italy), 1997, Volume: 9, Issue:4

    Topics: Aged; Aging; Alcoholism; Central Nervous System; Cerebrovascular Disorders; Cognition; Coronary Disease; Depression; Estrogens; Female; Folic Acid Deficiency; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylation; Peripheral Vascular Diseases; Renal Replacement Therapy; Vascular Diseases; Vitamin B 12 Deficiency

1997
Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Archives of internal medicine, 1997, Nov-10, Volume: 157, Issue:20

    Topics: Clinical Medicine; Coronary Disease; Evidence-Based Medicine; Homocysteine; Humans

1997
New risk factors for coronary heart disease in Asia.
    International journal of cardiology, 1997, Dec-01, Volume: 62 Suppl 1

    Topics: Adult; Aged; Aging; Asia; Child; Cholesterol, HDL; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Middle Aged; Obesity; Risk Factors; Smoking

1997
Folate and coronary heart disease.
    Current opinion in lipidology, 1998, Volume: 9, Issue:1

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Coronary Disease; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Nutrition Policy; Oxidoreductases; Polymorphism, Genetic; Risk Factors

1998
The role of homocysteine, folate and other B-vitamins in the development of atherosclerosis.
    Archivos latinoamericanos de nutricion, 1997, Volume: 47, Issue:2 Suppl 1

    Topics: Arteriosclerosis; Coronary Disease; Folic Acid; Hematinics; Homocysteine; Humans; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12; Vitamin B Complex

1997
Causes of coronary heart disease in patients on renal replacement therapy.
    Kidney & blood pressure research, 1998, Volume: 21, Issue:2-4

    Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors

1998
[The role of hyper-homocysteinemia in the etiology of some vascular diseases].
    Orvosi hetilap, 1998, Sep-13, Volume: 139, Issue:37

    Topics: Cerebrovascular Disorders; Coronary Disease; Diet Therapy; Female; Homocysteine; Humans; Male; Peripheral Vascular Diseases; Risk Factors; Vitamin B Complex

1998
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.
    Maturitas, 1998, Sep-20, Volume: 30, Issue:1

    Topics: Cholesterol; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Female; Homocysteine; Humans; Hypertension; Lipoprotein(a); Postmenopause; Risk Factors

1998
Should all elderly people receive folate supplements?
    Drugs & aging, 1998, Volume: 13, Issue:6

    Topics: Aged; Aging; Coronary Disease; Dietary Supplements; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Neoplasms; Nutritional Requirements; Nutritional Status

1998
Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
    Journal of cardiovascular risk, 1998, Volume: 5, Issue:4

    Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors

1998
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors.
    Current opinion in cardiology, 1999, Volume: 14, Issue:2

    Topics: Biomarkers; Coronary Disease; Diet; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Risk Factors; Triglycerides

1999
[The genetic component of coronary risk. II].
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:2

    Topics: Alleles; Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Genotype; Homocysteine; Humans; Models, Genetic; Mutation; Plasminogen Activators; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System; Research; Retrospective Studies; Risk Factors; Thrombosis

1999
New risk factors for coronary heart disease.
    The American journal of medicine, 1999, Aug-23, Volume: 107, Issue:2A

    Topics: Blood Coagulation Factors; C-Reactive Protein; Coronary Disease; Genotype; Homocysteine; Humans; Infections; Inflammation; Lipoprotein(a); Peptidyl-Dipeptidase A; Risk Factors

1999
Homocysteine: cholesterol of the 90s?
    Clinica chimica acta; international journal of clinical chemistry, 1999, Volume: 286, Issue:1-2

    Topics: Adult; Coronary Disease; Homocysteine; Humans; Practice Guidelines as Topic; Risk Factors; Vitamins

1999
[Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Deutsche medizinische Wochenschrift (1946), 1999, Sep-24, Volume: 124, Issue:38

    Topics: Age Factors; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Metabolism; Lipoproteins; Male; Meta-Analysis as Topic; Methionine; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors

1999
Novel risk factors and markers for coronary disease.
    Advances in internal medicine, 2000, Volume: 45

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis

2000
Moderate hyperhomocysteinemia and cardiovascular disease.
    The Journal of laboratory and clinical medicine, 2000, Volume: 135, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis

2000
Novel risk factors for coronary heart disease: emerging connections.
    The Journal of cardiovascular nursing, 2000, Volume: 14, Issue:2

    Topics: Arteriosclerosis; Coronary Disease; Hemostasis; Homocysteine; Humans; Hyperlipidemias; Inflammation; Iron; Lipoproteins; Risk Factors

2000
How accelerated atherosclerosis in SLE has changed our management of the disorder.
    Lupus, 2000, Volume: 9, Issue:3

    Topics: Antibodies, Antiphospholipid; Arteriosclerosis; Coronary Disease; Homocysteine; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Risk Factors

2000
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jul-11, Volume: 163, Issue:1

    Topics: Aged; Arteriosclerosis; Canada; Coronary Disease; Dietary Supplements; Disease Susceptibility; Fasting; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Methionine; Preventive Medicine; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12

2000
Risk factors for atherosclerosis in young individuals.
    Journal of cardiovascular risk, 2000, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Age Factors; Arteriosclerosis; Birth Weight; Blood Coagulation Factors; Child; Child, Preschool; Coronary Disease; Diabetes Complications; Exercise; Female; Homocysteine; Humans; Hypertension; Infant; Infant, Newborn; Insulin Resistance; Leptin; Life Style; Lipids; Lipoprotein(a); Male; Middle Aged; Obesity; Primary Prevention; Risk Factors; Sex Factors; Smoking

2000
Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis.
    The American journal of cardiology, 2000, Nov-01, Volume: 86, Issue:9

    Topics: Biomarkers; Case-Control Studies; Comorbidity; Coronary Disease; Female; Homocysteine; Homocystinuria; Humans; Incidence; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sensitivity and Specificity

2000
[Nutrition, dietary supplementation and coronary heart disease].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Sep-20, Volume: 120, Issue:22

    Topics: Coronary Disease; Dietary Fats; Dietary Supplements; Feeding Behavior; Female; Fish Oils; Folic Acid; Homocysteine; Humans; Lipoproteins; Male; Nutritional Physiological Phenomena; Nuts; Phytosterols; Pyridoxine; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12

2000
The role of folic acid in the prevention of cardiovascular disease.
    Current opinion in lipidology, 2000, Volume: 11, Issue:6

    Topics: Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Male; Models, Biological; Risk

2000
Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.
    Canadian family physician Medecin de famille canadien, 2000, Volume: 46

    Topics: Clinical Trials as Topic; Coronary Disease; Diet; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12

2000
Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.
    Basic research in cardiology, 2000, Volume: 95 Suppl 1

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Coronary Disease; Diet; Homocysteine; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Vitamin E

2000
Homocysteine: a new cardiac risk factor?
    Clinical cardiology, 2001, Volume: 24, Issue:1

    Topics: Coronary Artery Disease; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Risk Factors

2001
Hyperhomocysteinaemia and atherothrombosis.
    Annals of medicine, 2000, Volume: 32 Suppl 1

    Topics: Causality; Comorbidity; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Thrombosis

2000
Homocysteine and cardiovascular risk in patients with diabetes mellitus.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2001, Volume: 11, Issue:2

    Topics: Coronary Disease; Diabetes Complications; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Metformin; Risk Factors; Vitamin B Complex

2001
Risk factors for coronary heart disease: implications of gender.
    Cardiovascular research, 2002, Feb-15, Volume: 53, Issue:3

    Topics: Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Complications; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Lipid Metabolism; Male; Middle Aged; Obesity; Psychosocial Deprivation; Risk Factors; Sex; Smoking; Triglycerides

2002
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.
    International journal of epidemiology, 2002, Volume: 31, Issue:1

    Topics: Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Confounding Factors, Epidemiologic; Coronary Disease; Homocysteine; Humans; Risk Factors

2002
Risk factors for coronary artery disease in women.
    The American journal of cardiology, 2002, Jun-20, Volume: 89, Issue:12A

    Topics: C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Metabolic Syndrome; Risk Factors

2002
Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.
    PharmacoEconomics, 2002, Volume: 20, Issue:7

    Topics: Coronary Disease; Dietary Supplements; Economics, Pharmaceutical; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Vitamin B 12; Vitamin B 6

2002

Trials

39 trial(s) available for homocysteine and Coronary Disease

ArticleYear
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk.
    Journal of the American Geriatrics Society, 2014, Volume: 62, Issue:2

    Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Netherlands; Pravastatin; Prospective Studies; Scotland; Survival Rate; Time Factors; Treatment Outcome

2014
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
    Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20

    Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Hysterectomy; Inflammation; Insulin; Integrin beta3; Interleukin-6; Leukocyte Count; Matrix Metalloproteinase 9; Medroxyprogesterone; Middle Aged; Polymorphism, Genetic; Thrombosis; Triglycerides; von Willebrand Factor

2008
Utility of Framingham Coronary Heart Disease Risk Score for predicting cardiac risk after stroke.
    Stroke, 2012, Volume: 43, Issue:11

    Topics: Adult; Coronary Disease; Double-Blind Method; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Vitamins

2012
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
    The American journal of clinical nutrition, 2002, Volume: 76, Issue:2

    Topics: Blood Pressure; Cholesterol; Coronary Disease; Cross-Over Studies; Dietary Proteins; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperlipidemias; Isoflavones; Lipids; Male; Middle Aged; Postmenopause; Soybean Proteins

2002
Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.
    Clinical chemistry and laboratory medicine, 2002, Volume: 40, Issue:6

    Topics: Acute Disease; Aged; Blood Pressure; Body Mass Index; Coronary Disease; Diabetic Angiopathies; Dietary Supplements; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Reference Values; Vitamins

2002
Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.
    Circulation, 2002, Sep-10, Volume: 106, Issue:11

    Topics: Aged; Coronary Disease; Cross-Over Studies; Dietary Supplements; Eating; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lung; Male; Middle Aged; Nitric Oxide; Nuts; Prunus; Risk Factors

2002
Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Arteriosclerosis; Blood Flow Velocity; Cholesterol; Coronary Disease; Cross-Over Studies; Folic Acid; Forearm; Homocysteine; Humans; Male; Middle Aged; Placebos; Regional Blood Flow; Triglycerides; Vascular Resistance; Vitamin B 12

2002
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease.
    European heart journal, 2002, Volume: 23, Issue:19

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Australia; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Hematinics; Homocysteine; Humans; Male; Middle Aged; New Zealand; Pyridines; Thiazepines; Time Factors; Treatment Outcome

2002
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2002, Volume: 3, Issue:4

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelins; Female; Homocysteine; Humans; Male; Middle Aged; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Thiazepines

2002
Folate improves endothelial function in patients with coronary heart disease.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:11

    Topics: Administration, Oral; Brachial Artery; Coronary Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Regional Blood Flow; Tetrahydrofolates; Vasodilation

2003
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    JAMA, 2004, Feb-04, Volume: 291, Issue:5

    Topics: Adult; Aged; Coronary Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B 6

2004
Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Atherosclerosis, 2004, Volume: 174, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Postmenopause; Probability; Progesterone; Reference Values; Risk Assessment; Statistics, Nonparametric; Treatment Outcome

2004
Folate therapy and in-stent restenosis after coronary stenting.
    The New England journal of medicine, 2004, Jun-24, Volume: 350, Issue:26

    Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Stents; Treatment Failure; Vitamin B 12; Vitamin B 6

2004
Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
    Neuro endocrinology letters, 2004, Volume: 25, Issue:4

    Topics: Adult; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Hypothyroidism; Middle Aged; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Sterols; Triglycerides

2004
Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism.
    Circulation, 2006, Jan-03, Volume: 113, Issue:1

    Topics: Adolescent; Adult; Aged; Coronary Disease; Dietary Supplements; Drug Evaluation; Europe; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; North America; Polymorphism, Single Nucleotide; Riboflavin

2006
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:10

    Topics: Coronary Disease; Death, Sudden, Cardiac; Disease-Free Survival; Echocardiography, Stress; Female; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Regression Analysis; Renal Dialysis; Risk Factors; Secondary Prevention

2006
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Cardiology, 2007, Volume: 107, Issue:1

    Topics: Bezafibrate; Case-Control Studies; Coronary Disease; Death, Sudden, Cardiac; Female; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors

2007
Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
    European journal of clinical nutrition, 2008, Volume: 62, Issue:12

    Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cross-Over Studies; E-Selectin; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Homocysteine; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isoflavones; Middle Aged; Milk Proteins; Postmenopause; Soybean Proteins; Vascular Cell Adhesion Molecule-1

2008
High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease.
    Atherosclerosis, 1994, Volume: 111, Issue:2

    Topics: Ascorbic Acid; Coronary Disease; Homocysteine; Humans

1994
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting.
    The American journal of cardiology, 1994, Dec-01, Volume: 74, Issue:11

    Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Fatty Acids, Omega-3; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Prospective Studies; Vascular Patency

1994
Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.
    Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:6

    Topics: Adult; Coronary Disease; Cysteine; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Methylmalonic Acid; Middle Aged; Vitamin B 12

1997
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
    The New England journal of medicine, 1998, Apr-09, Volume: 338, Issue:15

    Topics: Aged; Aged, 80 and over; Coronary Disease; Cross-Over Studies; Double-Blind Method; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Homocystine; Humans; Male; Middle Aged; Nutrition Policy; Vitamins

1998
Lipid-lowering drugs and homocysteine.
    Lancet (London, England), 1999, Jan-16, Volume: 353, Issue:9148

    Topics: Amino Acids; Coronary Disease; Double-Blind Method; Fenofibrate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Simvastatin

1999
Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12.
    The American journal of cardiology, 1999, Mar-15, Volume: 83, Issue:6

    Topics: Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Pyridoxine; Single-Blind Method; Vitamin B 12

1999
Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls.
    Clinical chemistry, 2000, Volume: 46, Issue:2

    Topics: Arteriosclerosis; Chromatography, High Pressure Liquid; Coronary Disease; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Male; Middle Aged

2000
Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.
    Atherosclerosis, 2000, Volume: 149, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cells, Cultured; Chromatography, High Pressure Liquid; Confidence Intervals; Coronary Disease; Cystathionine beta-Synthase; Female; Genetic Variation; Homocysteine; Humans; Leukocytes, Mononuclear; Logistic Models; Male; Middle Aged; Mutation

2000
Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London.
    Atherosclerosis, 2000, Volume: 149, Issue:1

    Topics: Adult; Coronary Disease; Emigration and Immigration; Female; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Homocysteine; Humans; London; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Sri Lanka

2000
Strategies to optimize CAD prevention in modern cardiology. The "Marburg CAD Prevention Project".
    Herz, 2000, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Male; Middle Aged; Risk Factors; Triglycerides

2000
Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
    Molecular genetics and metabolism, 2000, Volume: 70, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Analysis of Variance; Coronary Disease; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Treatment Outcome

2000
Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.
    Circulation, 2000, Sep-12, Volume: 102, Issue:11

    Topics: Aged; Analysis of Variance; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prognosis; Prospective Studies; Risk Factors

2000
Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
    Journal of the American College of Cardiology, 2000, Volume: 36, Issue:3

    Topics: Aged; Antioxidants; Ascorbic Acid; Blood Circulation; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Nitroglycerin; Vasodilation; Vasodilator Agents; Vitamin B 12; Vitamin E

2000
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine.
    Circulation, 2000, Nov-14, Volume: 102, Issue:20

    Topics: Adult; Aged; Blood Glucose; Brachial Artery; Cholesterol; Cholesterol, HDL; Coronary Disease; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nitroglycerin; Regression Analysis; Triglycerides; Ultrasonography; Vasodilator Agents; Vitamin B 12

2000
Effect of alcohol intake on the levels of plasma homocysteine in healthy males.
    Journal of nutritional science and vitaminology, 2000, Volume: 46, Issue:4

    Topics: Adult; Alcohol Drinking; Aspartate Aminotransferases; Cholesterol, HDL; Coronary Disease; Epidemiologic Studies; Ethanol; gamma-Glutamyltransferase; Homocysteine; Humans; Male; Middle Aged; Triglycerides

2000
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease.
    Journal of the American College of Cardiology, 2001, Jun-01, Volume: 37, Issue:7

    Topics: Aged; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nitrates; Nitrites; Regional Blood Flow; von Willebrand Factor

2001
Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:7

    Topics: Animals; Biopterins; Cells, Cultured; Coronary Disease; Cross-Over Studies; Cytoplasm; Dietary Supplements; Dilatation, Pathologic; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Hemodynamics; Homocysteine; Humans; Injections, Intra-Arterial; Male; Middle Aged; Oxidative Stress; Superoxides; Tetrahydrofolates

2001
Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:12

    Topics: Area Under Curve; Blood Glucose; Carotenoids; Cholesterol, HDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Dinoprost; Edible Grain; F2-Isoprostanes; Fabaceae; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Powders; Risk Factors

2001
Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels.
    Clinical cardiology, 2002, Volume: 25, Issue:1

    Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Oxidation-Reduction; Risk Factors; Smoking; Smoking Cessation

2002
Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.
    Atherosclerosis, 2002, Volume: 162, Issue:1

    Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Genetic Markers; Genotype; Germany; Hemostasis; Homocysteine; Humans; Inflammation; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors

2002
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
    Circulation, 2002, Apr-16, Volume: 105, Issue:15

    Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors

2002

Other Studies

360 other study(ies) available for homocysteine and Coronary Disease

ArticleYear
[Correlation between Serum Homocysteine Level, MTHFR Gene Polymorphism and Patients with Hematological Diseases Complicated with Coronary Heart Disease].
    Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:1

    Topics: Coronary Disease; Genotype; Hematologic Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic

2022
Predictive Significance of High-Sensitivity C-Reactive Protein Combined with Homocysteine for Coronary Heart Disease in Patients with Anxiety Disorders.
    BioMed research international, 2022, Volume: 2022

    Topics: Anxiety Disorders; C-Reactive Protein; Coronary Disease; Homocysteine; Humans; Interleukin-6

2022
Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks.
    Scientific reports, 2022, 10-31, Volume: 12, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Gastritis; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Neural Networks, Computer; Spectroscopy, Fourier Transform Infrared; Tumor Necrosis Factor-alpha

2022
Genetic susceptibility, homocysteine levels, and risk of all-cause and cause-specific mortality: A prospective cohort study.
    Clinica chimica acta; international journal of clinical chemistry, 2023, Jan-01, Volume: 538

    Topics: Adult; Aged; Cause of Death; Coronary Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Middle Aged; Prospective Studies; Risk Factors

2023
Development and Validation of a Novel Model for Predicting Coronary Heart Disease in Snoring Hypertensive Patients with Hyperhomocysteinemia.
    International heart journal, 2023, Nov-30, Volume: 64, Issue:6

    Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Nomograms; Snoring

2023
Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:21

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; CD36 Antigens; Coronary Disease; Female; Fibrinogen; gamma-Glutamyltransferase; Homocysteine; Humans; Lipids; Male; Middle Aged

2019
Identifying gene-environment interactions on the efficacy of folic acid therapy for hyperhomocysteinemia based on prediction model.
    Nutrition research (New York, N.Y.), 2020, Volume: 77

    Topics: Aged; Algorithms; Coronary Disease; Female; Folic Acid; Gene-Environment Interaction; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Machine Learning; Male; Middle Aged; Models, Theoretical; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke; Treatment Failure; Treatment Outcome

2020
Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease.
    BioMed research international, 2020, Volume: 2020

    Topics: C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Risk Factors; RNA, Long Noncoding; Tumor Necrosis Factor-alpha

2020
Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease.
    Annals of palliative medicine, 2021, Volume: 10, Issue:5

    Topics: Aged; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Homocysteine; Humans; Nicotinamide Phosphoribosyltransferase

2021
MTHFR C677T Polymorphism and Serum Homocysteine Level as Risk Factors of Coronary Heart Disease in Patients with Androgenetic Alopecia: A Case Control Study.
    The American journal of the medical sciences, 2021, Volume: 362, Issue:4

    Topics: Adult; Alopecia; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Serum; Young Adult

2021
Descriptive study of relationship between cardio-ankle vascular index and biomarkers in vascular-related diseases.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:5

    Topics: Aged; Albuminuria; Biomarkers; Blood Pressure; Coronary Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Vascular Stiffness

2017
Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.
    Medicine, 2017, Volume: 96, Issue:51

    Topics: Age Factors; Body Mass Index; C-Reactive Protein; China; Coronary Disease; Diabetes Complications; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stroke

2017
High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
    Journal of epidemiology and community health, 2019, Volume: 73, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Stroke

2019
MicroRNA-128 confers protection against cardiac microvascular endothelial cell injury in coronary heart disease via negative regulation of IRS1.
    Journal of cellular physiology, 2019, Volume: 234, Issue:8

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Survival; Cells, Cultured; Coronary Disease; Endothelial Cells; Endothelium, Vascular; Homocysteine; Insulin Receptor Substrate Proteins; Male; MicroRNAs; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Up-Regulation; Vascular Endothelial Growth Factor A

2019
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
    Clinical nutrition (Edinburgh, Scotland), 2013, Volume: 32, Issue:2

    Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex

2013
Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
    Endocrine journal, 2013, Volume: 60, Issue:12

    Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Dietary Supplements; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Stroke; Vitamin B 12; Vitamin B 12 Deficiency

2013
Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
    Journal of cardiology, 2014, Volume: 64, Issue:4

    Topics: Adult; Biomarkers; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Assessment

2014
Multilocus heterozygosity and coronary heart disease: nested case-control studies in men and women.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Adiponectin; Adult; Aged; Biomarkers; Body Mass Index; Case-Control Studies; Cell Adhesion Molecules; Coronary Disease; Female; Follow-Up Studies; Genetic Loci; Genome-Wide Association Study; Health Personnel; Heterozygote; Homocysteine; Humans; Lipids; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors

2015
Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients: A Population-Based, Prospective Cohort Study.
    Stroke, 2015, Volume: 46, Issue:7

    Topics: Adult; Aged; Brain Ischemia; China; Cohort Studies; Coronary Disease; Female; Homocysteine; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Population Surveillance; Prospective Studies; Risk Factors; Stroke

2015
[A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients].
    Zhonghua nei ke za zhi, 2015, Volume: 54, Issue:4

    Topics: Antihypertensive Agents; Coronary Artery Disease; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hypertension; Incidence; Male; Prospective Studies; Socioeconomic Factors; Stroke

2015
The associations between serum biomarkers and stenosis of the coronary arteries.
    Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

    Topics: Adult; Aged; Biomarkers; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Disease; Coronary Vessels; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Surveys and Questionnaires; Triglycerides

2016
Daytime sleepiness is associated with hyperhomocysteinemia in rural area of China: A cross-sectional study.
    European journal of internal medicine, 2016, Volume: 35

    Topics: Adult; Aged; Apnea; China; Coronary Disease; Cross-Sectional Studies; Disorders of Excessive Somnolence; Female; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Risk Factors; Sex Factors; Sleep; Snoring; Stroke; Surveys and Questionnaires

2016
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
    Orphanet journal of rare diseases, 2016, 09-09, Volume: 11, Issue:1

    Topics: Apolipoproteins A; Apolipoproteins B; Blood Pressure; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipids; Male; Methionine; Phenylketonurias; Risk Factors; Triglycerides; Vitamin B 12

2016
Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:7

    Topics: Aged; C-Reactive Protein; Coronary Disease; Creatinine; Cross-Sectional Studies; Female; Ferritins; Homocysteine; Humans; Lipoproteins, HDL; Male; Risk Assessment; Risk Factors; Triglycerides; Uric Acid

2008
Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
    Fertility and sterility, 2009, Volume: 91, Issue:6

    Topics: Adult; Amenorrhea; Biomarkers; CD40 Ligand; Coronary Disease; Female; Homocysteine; Humans; Insulin; Oligomenorrhea; Polycystic Ovary Syndrome; Reference Values; Waist-Hip Ratio; Young Adult

2009
Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
    Clinical nutrition (Edinburgh, Scotland), 2008, Volume: 27, Issue:5

    Topics: Adult; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Linear Models; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Sex Factors; Turkey; Vitamin B 12

2008
Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.
    Clinical chemistry and laboratory medicine, 2008, Volume: 46, Issue:5

    Topics: Aged; Biomarkers; Coronary Angiography; Coronary Disease; Cysteine; Female; Homocysteine; Humans; Male; Middle Aged; Neopterin; Predictive Value of Tests; Sulfhydryl Compounds

2008
Homocysteine: the Rubik's cube of cardiovascular risk factors.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:11

    Topics: Atherosclerosis; Biomarkers; Coronary Disease; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Inflammation Mediators; Myocardial Infarction; Platelet Activation; Research Design; Risk Assessment; Risk Factors; Smoking; Stroke; Vascular Cell Adhesion Molecule-1; Vitamin B Complex

2008
Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents?
    Pediatrics international : official journal of the Japan Pediatric Society, 2008, Volume: 50, Issue:4

    Topics: Adolescent; C-Reactive Protein; Child; Child, Preschool; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors

2008
Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
    Annals of nutrition & metabolism, 2009, Volume: 54, Issue:1

    Topics: Adult; Anthropometry; Blood Pressure; Body Mass Index; Coronary Disease; Cross-Sectional Studies; Diet, Vegetarian; Female; Homocysteine; Humans; India; Life Style; Lipids; Male; Middle Aged; Risk Factors; Sex Factors; Waist Circumference

2009
[Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
    Wei sheng yan jiu = Journal of hygiene research, 2009, Volume: 38, Issue:1

    Topics: Adult; China; Coronary Disease; Cystathionine beta-Synthase; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic

2009
Vasculopathic and thrombophilic risk factors for spontaneous preterm birth.
    International journal of epidemiology, 2009, Volume: 38, Issue:3

    Topics: Adult; Case-Control Studies; Cholesterol, HDL; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Gestational Age; Homocysteine; Humans; Infant, Newborn; Placenta; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prospective Studies; Risk Factors; Stroke; Young Adult

2009
Depression, homocysteine concentration, and cardiovascular events.
    JAMA, 2009, Apr-15, Volume: 301, Issue:15

    Topics: Biomarkers; Coronary Disease; Depression; Depressive Disorder, Major; Homocysteine; Humans; Risk Factors

2009
Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
    Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 405, Issue:1-2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Coronary Disease; Female; Ferredoxin-NADP Reductase; Genotype; Glutamate Carboxypeptidase II; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors

2009
Exclusion of a case-control study from meta-analysis.
    Mayo Clinic proceedings, 2009, Volume: 84, Issue:6

    Topics: Case-Control Studies; Coronary Disease; Homocysteine; Humans; Meta-Analysis as Topic; Research; Risk Factors

2009
Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:8

    Topics: Adult; Aged; China; Cohort Studies; Coronary Disease; Death; Homocysteine; Humans; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; ROC Curve; Stroke

2009
Homocysteine level in Iranian patients with premature acute myocardial infarction.
    Chinese medical journal, 2009, Aug-20, Volume: 122, Issue:16

    Topics: Adult; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Male; Middle Aged; Myocardial Infarction; Risk Factors

2009
Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions.
    American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2009, Volume: 18, Issue:6

    Topics: Aged; Anger; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Hostility; Humans; Lipids; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors

2009
Task force: nontraditional markers add little to heart risk assessment.
    JAMA, 2009, Nov-25, Volume: 302, Issue:20

    Topics: Advisory Committees; American Heart Association; Ankle Brachial Index; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Arteries; Coronary Disease; Coronary Vessels; Homocysteine; Humans; Leukocyte Count; Lipoprotein(a); Practice Guidelines as Topic; Risk Assessment; Societies, Medical; United States

2009
[Side effects of caffeine].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2009, Volume: 27, Issue:161

    Topics: Abortion, Spontaneous; Arteries; Caffeine; Cholesterol; Coronary Disease; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; DNA Copy Number Variations; Elasticity; Esophageal Sphincter, Lower; Female; Fetal Growth Retardation; Glucose; Homocysteine; Humans; Hypertension; Insulin Resistance; Pregnancy; Risk Factors

2009
Homocysteine, fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children.
    Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:10

    Topics: Atherosclerosis; Autoantibodies; Biomarkers; Child; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipoproteins, LDL; Male; Obesity

2009
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.
    Circulation. Cardiovascular quality and outcomes, 2008, Volume: 1, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Assessment; Risk Factors

2008
Homocysteine in angiographically proven coronary disease.
    Medicinski arhiv, 2009, Volume: 63, Issue:5

    Topics: Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipid A; Male

2009
[Levels of homocysteine in blood serum--new coronary risk factors--in adult residents of our country. Results of the WOBASZ program].
    Kardiologia polska, 2005, Volume: 63, Issue:6 Suppl 4

    Topics: Adult; Age Distribution; Aged; Coronary Disease; Female; Homocysteine; Humans; Male; Mass Screening; Middle Aged; Poland; Risk Factors; Sex Distribution; Young Adult

2005
Mendelian randomisation: a tool for assessing causality in observational epidemiology.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 713

    Topics: Alcohol Drinking; Blood Pressure; Causality; Coronary Disease; Fibrinogen; Homocysteine; Humans; Mendelian Randomization Analysis; Molecular Epidemiology; Stroke

2011
What is the role of alternative biomarkers for coronary heart disease?
    Clinical endocrinology, 2011, Volume: 75, Issue:3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors

2011
Homocysteine, B vitamins, and the risk of cardiovascular disease.
    Clinical chemistry, 2011, Volume: 57, Issue:8

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Vascular Diseases; Risk; Vitamin B Complex

2011
Homocysteine-induced caspase-3 activation by endoplasmic reticulum stress in endothelial progenitor cells from patients with coronary heart disease and healthy donors.
    Bioscience, biotechnology, and biochemistry, 2011, Volume: 75, Issue:7

    Topics: Animals; Apoptosis; Blood Donors; Calcium Signaling; Caspase 3; Cell Line; Cinnamates; Coronary Disease; Endoplasmic Reticulum; Endothelial Cells; Homocysteine; HSP70 Heat-Shock Proteins; Humans; Male; Membrane Proteins; Oxidative Stress; Phosphorylation; Stem Cells; Thiourea

2011
Premature coronary heart disease risk factors & reducing the CHD burden in India.
    The Indian journal of medical research, 2011, Volume: 134

    Topics: Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Homocysteine; Humans; Male; Thrombosis

2011
Atherothrombotic risk factors & premature coronary heart disease in India: a case-control study.
    The Indian journal of medical research, 2011, Volume: 134

    Topics: Adult; Atherosclerosis; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Eating; Female; Fibrinogen; Homocysteine; Humans; India; Logistic Models; Male; Middle Aged; Platelet Count; Risk Factors; Smoking; Thrombosis; Triglycerides

2011
Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
    European journal of preventive cardiology, 2012, Volume: 19, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Down-Regulation; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; New South Wales; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Up-Regulation; Vitamin B 12

2012
Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: appraisal of a recent meta-analysis.
    DNA and cell biology, 2012, Volume: 31, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Coronary Disease; Ferredoxin-NADP Reductase; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide

2012
Homocysteine and cardiovascular risk: the perils of reductionism in a complex system.
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Animals; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk; Vitamin B Complex

2012
Relative importance of risk factors for coronary heart disease--the Hordaland Homocysteine study.
    Scandinavian cardiovascular journal : SCJ, 2012, Volume: 46, Issue:6

    Topics: Adult; Age Factors; Aged; Biomarkers; Chi-Square Distribution; Cholesterol; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Triglycerides

2012
[Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease].
    Annales de biologie clinique, 2012, Oct-01, Volume: 70, Issue:5

    Topics: Adult; Aged; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Peptidyl-Dipeptidase A; Risk Factors; Tunisia

2012
Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.
    Clinical nutrition (Edinburgh, Scotland), 2013, Volume: 32, Issue:2

    Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Myocardial Infarction; Stroke; Vitamin B Complex

2013
Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high-risk families.
    European journal of clinical investigation, 2002, Volume: 32, Issue:7

    Topics: Biomarkers; Blood Glucose; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Complications; Diabetes Mellitus; Diagnosis, Computer-Assisted; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Risk Factors

2002
Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.
    Diabetes research and clinical practice, 2002, Volume: 58, Issue:1

    Topics: Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Homocysteine; Humans; Interleukin-6; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Regression Analysis; Risk Factors

2002
Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    The Journal of the Association of Physicians of India, 2002, Volume: 50 Suppl

    Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Vitamin B 12

2002
Homocysteine and vascular disease.
    European heart journal, 2002, Volume: 23, Issue:19

    Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Folic Acid; Hematinics; Homocysteine; Humans; Pyridines; Thiazepines; Vascular Diseases

2002
Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.
    Atherosclerosis, 2002, Volume: 165, Issue:2

    Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Severity of Illness Index; Vitamin B 12

2002
High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults.
    European journal of clinical investigation, 2002, Volume: 32, Issue:11

    Topics: Adenosine; Adult; Autoantibodies; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol; Cholesterol, HDL; Coronary Circulation; Coronary Disease; Ferritins; Homocysteine; Humans; Image Processing, Computer-Assisted; Linear Models; Lipoproteins, LDL; Male; Regional Blood Flow; Risk Factors; Smoking; Tomography, Emission-Computed; Triglycerides

2002
Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting.
    The Annals of thoracic surgery, 2002, Volume: 74, Issue:5

    Topics: Aged; Cardiopulmonary Bypass; Ceruloplasmin; Copper; Coronary Artery Bypass; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Postoperative Complications; Risk Factors; Vitamin B 12

2002
Does short-term smoking cessation reduce plasma total homocysteine concentrations?
    Scandinavian journal of clinical and laboratory investigation, 2002, Volume: 62, Issue:4

    Topics: Adult; Body Mass Index; Cholesterol, HDL; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Random Allocation; Risk Factors; Smoking; Smoking Cessation

2002
Plasma homocysteine in subjects with familial combined hyperlipidemia.
    Atherosclerosis, 2003, Volume: 166, Issue:1

    Topics: Adult; Apolipoproteins B; Blood Pressure; Body Mass Index; Cholesterol; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemia, Familial Combined; Insulin Resistance; Male; Middle Aged; Regression Analysis; Risk Factors

2003
Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans--causes and implications.
    Atherosclerosis, 2003, Volume: 166, Issue:1

    Topics: Adult; Arabs; Cholesterol, LDL; Coronary Disease; Female; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylmalonic Acid; Middle Aged; Prevalence; Syria; Vitamin D Deficiency

2003
Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
    Acta diabetologica, 2002, Volume: 39, Issue:4

    Topics: Albuminuria; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Osmolar Concentration

2002
Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study.
    Atherosclerosis, 2003, Volume: 166, Issue:2

    Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Confidence Intervals; Coronary Disease; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Netherlands; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate; Vitamin B Complex

2003
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.
    International journal of epidemiology, 2002, Volume: 31, Issue:6

    Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Prospective Studies; Risk Factors

2002
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
    Clinical nephrology, 2003, Volume: 59, Issue:2

    Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors

2003
Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.
    Stroke, 2003, Volume: 34, Issue:3

    Topics: Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Israel; Male; Matched-Pair Analysis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Odds Ratio; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke

2003
Homocysteine testing.
    Critical care nurse, 2003, Volume: 23, Issue:2

    Topics: Coronary Disease; Female; Homocysteine; Humans; Male

2003
Folate and risk of cardiovascular disease. Study results were misinterpreted.
    BMJ (Clinical research ed.), 2003, May-10, Volume: 326, Issue:7397

    Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Data Interpretation, Statistical; Folic Acid; Homocysteine; Humans; Meta-Analysis as Topic; Risk Factors

2003
Serum homocysteine levels and mortality in outpatients with or without coronary artery disease: an observational study.
    The American journal of medicine, 2003, Jun-01, Volume: 114, Issue:8

    Topics: Aged; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Factors

2003
The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study.
    Thrombosis research, 2003, May-01, Volume: 110, Issue:2-3

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenine; Case-Control Studies; Coronary Disease; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Guanine; Homocysteine; Humans; Middle Aged; Osmolar Concentration; Risk Factors; Vitamin B 12

2003
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease.
    Atherosclerosis, 2003, Volume: 169, Issue:2

    Topics: Adult; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Triglycerides; Twins, Monozygotic

2003
Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:6

    Topics: Aged; Aged, 80 and over; Coronary Disease; Creatinine; Fasting; Female; Folic Acid; Health Surveys; Homocysteine; Humans; Hypothyroidism; Male; New Mexico; Prevalence; Risk Factors; Vitamin B 12

2003
Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries.
    The Journal of surgical research, 2003, Volume: 115, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blotting, Western; Bradykinin; Coronary Disease; Coronary Vessels; Culture Media; Culture Techniques; Endothelium, Vascular; Gene Expression; Homocysteine; Immunohistochemistry; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Wine

2003
Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
    Acta cardiologica, 2003, Volume: 58, Issue:5

    Topics: Aged; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Exercise Test; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Ultrasonography; Vasodilation; Vitamin B 12; Vitamin B 6

2003
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:11

    Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins; Lupus Erythematosus, Systemic; Ontario; Risk; Risk Factors

2003
[Homocysteine and progression of carotid atherosclerosis in patients with coronary disease].
    Medicina clinica, 2003, Nov-01, Volume: 121, Issue:15

    Topics: Arteriosclerosis; Carotid Artery Diseases; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged

2003
The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:11

    Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors

2003
Evidence suggests diabetes outcomes linked to homocysteine.
    Nephrology news & issues, 2003, Volume: 17, Issue:13

    Topics: Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex

2003
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
    Annals of internal medicine, 2004, Jan-06, Volume: 140, Issue:1

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors

2004
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.
    Annals of internal medicine, 2004, Jan-06, Volume: 140, Issue:1

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors

2004
Effect of folic acid fortification of food on homocysteine-related mortality.
    The American journal of medicine, 2004, Feb-01, Volume: 116, Issue:3

    Topics: Aged; Coronary Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Risk Factors

2004
Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.
    Circulation, 2004, Feb-10, Volume: 109, Issue:5

    Topics: Adult; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk Factors; Sweden

2004
Serum total homocysteine levels, folate, and B-vitamins intake and coronary heart disease risk factors among tri-ethnic college students.
    Ethnicity & disease, 2004,Winter, Volume: 14, Issue:1

    Topics: Adult; Black or African American; Coronary Disease; Female; Florida; Folic Acid; Hispanic or Latino; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Male; Risk Factors; Sex Factors; Smoking; Universities; Vitamin B 12; Vitamin B 6; White People

2004
Eat right and exercise for lower homocysteine levels and less chance of heart disease.
    Ethnicity & disease, 2004,Winter, Volume: 14, Issue:1

    Topics: Adult; Age Factors; Coronary Disease; Exercise; Feeding Behavior; Female; Florida; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6

2004
Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Current medical research and opinion, 2004, Volume: 20, Issue:2

    Topics: Adult; Aged; Biomarkers; Case-Control Studies; Coronary Disease; Female; Greece; Homocysteine; Humans; Logistic Models; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors

2004
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    International journal of cardiology, 2004, Volume: 94, Issue:2-3

    Topics: Aged; Biomarkers; Clinical Trials as Topic; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care; P-Selectin; Platelet Activation; Risk Factors; Stroke; von Willebrand Factor

2004
VISP and INVEST.
    Preventive cardiology, 2004,Spring, Volume: 7, Issue:2

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Coronary Disease; Homocysteine; Humans; Hypertension; Indoles; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Verapamil; Vitamins

2004
Elevated levels of plasma homocysteine are associated with neurotoxicity.
    Atherosclerosis, 2004, Volume: 174, Issue:1

    Topics: Aged; Biomarkers; Comorbidity; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotoxicity Syndromes; Probability; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Statistics, Nonparametric

2004
Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2004, Volume: 11, Issue:3

    Topics: Case-Control Studies; Coronary Disease; Creatinine; Female; Folic Acid; Genotype; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prevalence; Retrospective Studies; Vitamin B 12

2004
Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts.
    Advances in experimental medicine and biology, 2003, Volume: 527

    Topics: Biomarkers; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Kynurenine; Neopterin; Prognosis; Pyridoxal Phosphate; Tryptophan

2003
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:9

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines

2004
Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    The American journal of clinical nutrition, 2004, Volume: 80, Issue:2

    Topics: Coronary Disease; Finland; Folic Acid; Homocysteine; Humans; Incidence; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors

2004
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
    Circulation, 2004, Jul-27, Volume: 110, Issue:4

    Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors

2004
Increased plasma homocysteine concentrations in healthy people with hostile behavior: the ATTICA study.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:8

    Topics: Adult; Coronary Disease; Feeding Behavior; Female; Fibrinogen; Greece; Homocysteine; Hostility; Humans; Leukocyte Count; Life Style; Male; Middle Aged; Smoking

2004
Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2004, Volume: 87, Issue:6

    Topics: Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Logistic Models; Male; Seroepidemiologic Studies; Thailand; Vitamin B 12

2004
Homocysteine and cardiovascular disease: a 17-year follow-up study in Busselton.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2004, Volume: 11, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Australia; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Confounding Factors, Epidemiologic; Coronary Disease; Creatinine; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors; Stroke

2004
Incorporating cardiovascular disease risk stratification into clinical decision making.
    JAAPA : official journal of the American Academy of Physician Assistants, 2004, Volume: 17, Issue:5

    Topics: Adult; C-Reactive Protein; Coronary Disease; Decision Making; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Peroxidase; Risk Assessment

2004
An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization.
    American journal of epidemiology, 2004, Sep-01, Volume: 160, Issue:5

    Topics: Confidence Intervals; Coronary Disease; Genotype; Homocysteine; Humans; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Random Allocation

2004
Folate therapy and in-stent restenosis.
    The New England journal of medicine, 2004, Sep-16, Volume: 351, Issue:12

    Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Stents; Vitamin B 6; Vitamin B Complex

2004
Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric Acid reactive system in children with high coronary risk family history.
    Journal of the American College of Nutrition, 2004, Volume: 23, Issue:5

    Topics: Adolescent; Carbon-Nitrogen Ligases; Case-Control Studies; Child; Child, Preschool; Coronary Disease; Female; Fluorometry; Genetic Markers; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Male; Polymorphism, Restriction Fragment Length; Risk Factors; Thiobarbituric Acid Reactive Substances

2004
Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters.
    Seminars in vascular medicine, 2004, Volume: 4, Issue:2

    Topics: C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronary Disease; Endothelium, Vascular; Fibrinolysis; Homocysteine; Humans; Hypothyroidism; Risk Factors; Thyroid Hormones; Thyroxine; von Willebrand Diseases

2004
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Circulation, 2004, Nov-02, Volume: 110, Issue:18

    Topics: Adult; Apolipoprotein B-100; Apolipoproteins B; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Lipids; Middle Aged; Myocardial Infarction; Postmenopause; Practice Guidelines as Topic; Risk; Single-Blind Method; Triglycerides

2004
[The relationship between serum calcitonin gene-related peptide, sex hormone, homocysteine and coronary artery disease in postmenopausal women].
    Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:9

    Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Coronary Disease; Cross-Sectional Studies; Estradiol; Female; Homocysteine; Humans; Logistic Models; Middle Aged; Postmenopause; Progesterone; Risk Factors

2004
Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
    Circulation, 2004, Nov-02, Volume: 110, Issue:18

    Topics: Adolescent; Adult; Arteriosclerosis; Blood Glucose; Body Mass Index; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Child; Child, Preschool; Cholesterol; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Finland; Follow-Up Studies; Hemorheology; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sampling Studies; Sex Factors; Smoking; Tunica Intima; Tunica Media; Ultrasonography; Vasodilation; Waist-Hip Ratio

2004
Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors.
    Atherosclerosis, 2004, Volume: 177, Issue:2

    Topics: C-Reactive Protein; Cholesterol; Cholesterol, HDL; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Receptors, Tumor Necrosis Factor; Risk Factors; Thiamine

2004
Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:11

    Topics: Coronary Disease; Disease Progression; Female; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Time Factors

2004
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
    Chinese medical journal, 2004, Volume: 117, Issue:11

    Topics: Acute Disease; Adult; Aged; Chemokine CCL2; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase

2004
Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients.
    Molecular and cellular endocrinology, 2005, Jan-14, Volume: 229, Issue:1-2

    Topics: Asian People; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors

2005
Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients.
    European journal of clinical investigation, 2005, Volume: 35, Issue:1

    Topics: Adult; Biomarkers; Blood Coagulation; Case-Control Studies; Chelating Agents; Coronary Disease; Fasting; Female; Folic Acid Deficiency; Homocysteine; Humans; Lipoprotein(a); Male; Methionine; Middle Aged; Risk; Statistics, Nonparametric; Thromboplastin; Vitamin B 12 Deficiency

2005
Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk.
    Cellular and molecular biology (Noisy-le-Grand, France), 2004, Volume: 50, Issue:8

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Female; Germany; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Risk; Risk Factors; Syria; Time Factors

2004
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
    Vnitrni lekarstvi, 2004, Volume: 50, Issue:12

    Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid

2004
Plasma homocysteine concentrations in Greek children are influenced by an interaction between the methylenetetrahydrofolate reductase C677T genotype and folate status.
    The Journal of nutrition, 2005, Volume: 135, Issue:3

    Topics: Biomarkers; Child; Coronary Disease; Female; Folic Acid; Genotype; Greece; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Risk Factors

2005
Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?
    International journal of cardiology, 2005, Apr-20, Volume: 100, Issue:2

    Topics: Aged; Analysis of Variance; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Linear Models; Male; Myocardial Infarction; Prognosis; Spain; Survival Analysis

2005
The relation between homocysteine and calcific aortic valve stenosis.
    Cardiology, 2005, Volume: 103, Issue:4

    Topics: Age Factors; Aged; Aortic Valve Stenosis; Calcinosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk Factors; Smoking; Triglycerides

2005
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach.
    Statistics in medicine, 2005, Jul-30, Volume: 24, Issue:14

    Topics: Coronary Disease; Homocysteine; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Models, Genetic; Models, Statistical; Multivariate Analysis; Polymorphism, Genetic

2005
Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.
    Journal of the American College of Cardiology, 2005, May-17, Volume: 45, Issue:10

    Topics: Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Cardiovascular Diseases; Coronary Disease; Early Diagnosis; Female; Follow-Up Studies; Germany; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Survival Rate

2005
Plasma homocysteine predicts progression of atherosclerosis.
    Atherosclerosis, 2005, Volume: 181, Issue:1

    Topics: Adult; Aged; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed

2005
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Atherosclerosis, 2006, Volume: 184, Issue:2

    Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking

2006
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:6

    Topics: Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Estrogen Replacement Therapy; Female; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Lipids; Middle Aged; Prospective Studies; Risk Factors; Tissue Plasminogen Activator

2005
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Disease; Factor V; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Recurrence; Regression Analysis; Risk Factors; Stents; Syndrome; Thrombophilia

2006
A homocysteine metabolism-related dietary pattern and the risk of coronary heart disease in two independent German study populations.
    The Journal of nutrition, 2005, Volume: 135, Issue:8

    Topics: Aged; Body Mass Index; Case-Control Studies; Coronary Disease; Diet; Female; Folic Acid; Germany; Homocysteine; Humans; Middle Aged; Multivariate Analysis; Risk Factors; Vitamin B 12

2005
Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 364, Issue:1-2

    Topics: Adult; Alleles; Aryldialkylphosphatase; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors

2006
[Effect of the supplementation of vitamins B12, B6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV].
    Archivos latinoamericanos de nutricion, 2005, Volume: 55, Issue:1

    Topics: Adult; Aged; Biomarkers; Cholesterol, HDL; Coronary Disease; Folic Acid; Homocysteine; Humans; Hyperlipoproteinemia Type IV; Lipids; Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2005
Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso.
    Clinical chemistry and laboratory medicine, 2005, Volume: 43, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Chemical Analysis; Burkina Faso; Coronary Disease; Female; Homocysteine; Humans; Menopause; Middle Aged; Sulfhydryl Compounds

2005
[For coronary disease patients risky].
    MMW Fortschritte der Medizin, 2005, Oct-20, Volume: 147, Issue:42

    Topics: Adult; Clinical Trials as Topic; Coronary Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Middle Aged; Reference Values; Risk Factors; Vitamin B 6; Vitamins

2005
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome.
    Heart and vessels, 2005, Volume: 20, Issue:6

    Topics: Adult; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Male; Metabolic Syndrome; Middle Aged; Reference Values; Risk Factors; Statistics as Topic; Turkey; Vitamin B 12

2005
New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2005, Volume: 12, Issue:6

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Coronary Disease; Cysteine; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prognosis; Retrospective Studies; Risk Factors; Smoking; von Willebrand Factor

2005
Plasma total homocysteine and gallstone in middle-aged Japanese men.
    Journal of gastroenterology, 2005, Volume: 40, Issue:11

    Topics: Alcohol Drinking; Blood Glucose; Coronary Disease; Diet; Folic Acid; Gallstones; gamma-Glutamyltransferase; Homocysteine; Humans; Japan; Lipids; Male; Middle Aged; Risk Factors; Smoking

2005
Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
    International journal of cardiology, 2006, Jun-16, Volume: 110, Issue:2

    Topics: Administration, Oral; Antioxidants; Ascorbic Acid; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Methionine

2006
Elevated plasma homocysteine levels in patients with isolated coronary artery ectasia.
    Coronary artery disease, 2006, Volume: 17, Issue:1

    Topics: Biomarkers; Coronary Angiography; Coronary Disease; Dilatation, Pathologic; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors

2006
Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.
    Journal of the Chinese Medical Association : JCMA, 2005, Volume: 68, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Vitamin B 12; Vitamin B 6

2005
Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Journal of tropical pediatrics, 2006, Volume: 52, Issue:4

    Topics: Adolescent; Child; Coronary Disease; Diabetes Mellitus, Type 1; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors; Vitamins

2006
Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk.
    Mayo Clinic proceedings, 2006, Volume: 81, Issue:2

    Topics: Aged; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed

2006
High dietary methionine intake increases the risk of acute coronary events in middle-aged men.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2006, Volume: 16, Issue:2

    Topics: Acute Disease; Adult; Cohort Studies; Coronary Disease; Diet Records; Dietary Proteins; Finland; Follow-Up Studies; Homocysteine; Humans; Male; Methionine; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors

2006
Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
    International journal of cardiology, 2006, Mar-22, Volume: 108, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Homocysteine; Humans; Male; Middle Aged; Postoperative Care; Predictive Value of Tests; Pregnancy; Statistics, Nonparametric; Stents

2006
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.
    Clinical chemistry, 2006, Volume: 52, Issue:5

    Topics: Aged; Aged, 80 and over; Blood Glucose; Body Weights and Measures; Butyrylcholinesterase; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Israel; Life Style; Lipids; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Socioeconomic Factors

2006
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Internal medicine journal, 2006, Volume: 36, Issue:4

    Topics: Adult; Arteries; Blood Pressure; Case-Control Studies; CD40 Antigens; Cholesterol, LDL; Coronary Disease; Elasticity; Endothelium, Vascular; Female; Homocysteine; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Risk Factors; Severity of Illness Index; Vascular Cell Adhesion Molecule-1

2006
Homocysteine and coronary heart disease risk in the PRIME study.
    Atherosclerosis, 2007, Volume: 191, Issue:1

    Topics: Biomarkers; Case-Control Studies; Cohort Studies; Coronary Disease; France; Homocysteine; Humans; Male; Middle Aged; Northern Ireland; Prospective Studies; Risk; Smoking

2007
Homocysteine, folate and vitamin b12 in patients with coronary heart disease.
    Annals of nutrition & metabolism, 2006, Volume: 50, Issue:5

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Creatinine; Diet; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Vitamin B 12; Vitamin B Complex

2006
[Peculiarities of atherosclerotic injury of carotid arteries in patients with coronary artery disease with hyperhomocysteinemia].
    Kardiologiia, 2006, Volume: 46, Issue:5

    Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Severity of Illness Index; Ultrasonography

2006
Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
    Journal of the National Medical Association, 2006, Volume: 98, Issue:8

    Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome

2006
Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.
    Heart (British Cardiac Society), 2007, Volume: 93, Issue:2

    Topics: Adult; Biomarkers; Cerebrovascular Disorders; Chelating Agents; Coronary Disease; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Methionine; Middle Aged; Peripheral Vascular Diseases; Proportional Hazards Models; Risk Assessment

2007
13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.
    Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:6

    Topics: Aged; Ammonia; Coronary Angiography; Coronary Disease; Exercise Test; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Reference Values

2006
[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:9

    Topics: Adult; Aged; Aryldialkylphosphatase; Coronary Disease; Cysteine; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic

2006
Is any link between inflammation and coronary artery ectasia?
    Medical hypotheses, 2007, Volume: 69, Issue:3

    Topics: Aged; Angiography; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Genotype; Heterozygote; Homocysteine; Humans; Inflammation; Male; Middle Aged; Models, Biological; Peptidyl-Dipeptidase A

2007
Plasma homocysteine concentration in patients with poor or good coronary collaterals.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:2

    Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Collateral Circulation; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio

2007
Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.
    PloS one, 2007, Jan-31, Volume: 2, Issue:1

    Topics: Adult; Catechol O-Methyltransferase; Cohort Studies; Coronary Disease; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Prospective Studies; Risk Factors

2007
Hypothyroidism in coronary heart disease and its relation to selected risk factors.
    Vascular health and risk management, 2006, Volume: 2, Issue:4

    Topics: Adult; Aged; Autoantibodies; Autoantigens; Coronary Disease; Cross-Sectional Studies; Czech Republic; Female; Homocysteine; Humans; Hypercholesterolemia; Hypothyroidism; Iodide Peroxidase; Iron-Binding Proteins; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Severity of Illness Index; Sex Distribution; Sex Factors; Thyrotropin; Time Factors; von Willebrand Factor

2006
Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
    Annals of nutrition & metabolism, 2007, Volume: 51, Issue:1

    Topics: Adult; Aged; Body Mass Index; Coronary Disease; Dyslipidemias; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Immunoassay; Male; Middle Aged; Risk Factors

2007
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
    International journal of cardiology, 2008, Mar-14, Volume: 124, Issue:3

    Topics: Acute Disease; Biomarkers; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Greece; Homocysteine; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Syndrome; Time Factors

2008
The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
    Cellular and molecular biology (Noisy-le-Grand, France), 2006, Dec-31, Volume: 52, Issue:5

    Topics: Adult; Aged; Animals; Aryldialkylphosphatase; Cholesterol; Coronary Disease; Genotype; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Statistics as Topic

2006
Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.
    Journal of thrombosis and thrombolysis, 2009, Volume: 27, Issue:1

    Topics: Aged; Amino Acid Substitution; Arterial Occlusive Diseases; Brain Ischemia; Brazil; Comorbidity; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors

2009
Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study.
    Atherosclerosis, 2008, Volume: 198, Issue:2

    Topics: Adult; Aged; Asian People; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Japan; Male; Middle Aged; Risk; Stroke

2008
Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
    Metabolism: clinical and experimental, 1983, Volume: 32, Issue:4

    Topics: Adult; Amino Acids, Sulfur; Aminobutyrates; Coronary Disease; Diseases in Twins; Female; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Pregnancy; Twins, Monozygotic

1983
Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.
    Atherosclerosis, 1995, Volume: 116, Issue:1

    Topics: Adult; Aged; Cohort Studies; Coronary Disease; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Predictive Value of Tests; Risk Factors

1995
[Homocysteinemia as a risk factor for myocardial infarct--the importance of age and of the homocysteinemia levels].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1995, Volume: 14, Issue:10

    Topics: Adult; Aging; Case-Control Studies; Confidence Intervals; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors

1995
Effective homocysteine metabolism may protect South African blacks against coronary heart disease.
    The American journal of clinical nutrition, 1995, Volume: 62, Issue:4

    Topics: Adult; Black People; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Methionine; South Africa; Vitamin B 12; Vitamins; White People

1995
Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine.
    Clinical chemistry, 1995, Volume: 41, Issue:7

    Topics: Adolescent; Adult; Coronary Disease; Homocysteine; Humans; Male; Mathematics; Middle Aged; Models, Biological; Reference Values; Risk Factors; Vitamin B Complex

1995
Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:9

    Topics: Adult; Aged; Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Male; Middle Aged; Pyridoxine; Regression Analysis; Risk Factors; Vitamin B 12

1995
Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate.
    The American journal of cardiology, 1995, Jun-01, Volume: 75, Issue:16

    Topics: Adult; Chi-Square Distribution; Coronary Disease; Discriminant Analysis; Female; Folic Acid; France; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Pyridoxal Phosphate; Pyridoxine; Quebec; Regression Analysis; Risk Factors; Sex Factors; Vitamin B 12; Vitamin B Complex

1995
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.
    The American journal of cardiology, 1995, Jan-15, Volume: 75, Issue:2

    Topics: Aged; Analysis of Variance; Arteriosclerosis; Coronary Disease; Cystathionine; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Methylmalonic Acid; Middle Aged; Pyridoxine; Risk Factors

1995
Hyperhomocysteinaemia in heart transplant recipients.
    European heart journal, 1994, Volume: 15, Issue:9

    Topics: Aged; Coronary Angiography; Coronary Disease; Fasting; Female; Heart Transplantation; Homocysteine; Humans; Male; Methionine; Middle Aged; Postoperative Complications; Renal Insufficiency

1994
Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:3

    Topics: Adult; Age Factors; Blood Viscosity; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Risk Factors

1994
Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.
    The American journal of clinical nutrition, 1994, Volume: 59, Issue:4

    Topics: Adult; Case-Control Studies; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vitamin B 12

1994
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.
    Clinical chemistry, 1994, Volume: 40, Issue:4

    Topics: Adult; Age Factors; Aged; Cholesterol, LDL; Coronary Disease; Creatinine; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Reference Values; Regression Analysis; Risk Factors; Smoking; Uric Acid; Vitamins

1994
The case that hyperhomocysteinemia is a risk factor for coronary artery disease.
    The American journal of cardiology, 1994, Apr-01, Volume: 73, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Risk Factors

1994
Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?
    The Quarterly journal of medicine, 1993, Volume: 86, Issue:10

    Topics: Adult; Coronary Disease; Female; Gene Frequency; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Prevalence

1993
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular disease.
    Atherosclerosis, 1993, Volume: 102, Issue:1

    Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vascular Diseases

1993
Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:9

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adolescent; Adult; Aged; Betaine-Homocysteine S-Methyltransferase; Cerebrovascular Disorders; Coronary Disease; Cystathionine beta-Synthase; Female; Homocysteine; Humans; Male; Methionine; Methyltransferases; Middle Aged; Peripheral Vascular Diseases; Vitamins

1993
Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:1

    Topics: Adult; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Fasting; Female; Folic Acid; Homocysteine; Humans; Leg; Male; Methionine; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12

1996
Serum total homocysteine and coronary heart disease.
    International journal of epidemiology, 1995, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Child; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Prospective Studies; Regression Analysis; Risk Factors

1995
Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.
    Progress in cardiovascular nursing, 1995,Fall, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors

1995
Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:6

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Cohort Studies; Coronary Disease; Erythrocytes; Female; Follow-Up Studies; Homocysteine; Humans; Isoenzymes; Lymphocytes; Male; Methionine Adenosyltransferase; Methylation; Middle Aged; Risk Factors; S-Adenosylmethionine; Tetrahydrofolates

1996
Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence.
    The Journal of nutrition, 1996, Volume: 126, Issue:4 Suppl

    Topics: Adult; Black People; Coronary Disease; Homocysteine; Humans; Male; Prevalence; South Africa; White People

1996
Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: association between vitamin B-12 deficiency and decreased left ventricular ejection fraction.
    The Journal of nutrition, 1996, Volume: 126, Issue:4 Suppl

    Topics: Aged; Animals; Coronary Disease; Female; Homocysteine; Humans; Male; Rats; Stroke Volume; Ventricular Function, Left; Vitamin B 12 Deficiency

1996
Homocysteinaemia after methionine overload as a coronary artery disease risk factor: importance of age and homocysteine levels.
    Coronary artery disease, 1995, Volume: 6, Issue:11

    Topics: Age Factors; Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors

1995
[Homocysteine, a less well-known risk factor in cardiac and vascular diseases].
    Casopis lekaru ceskych, 1996, May-02, Volume: 135, Issue:9

    Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors

1996
Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease?
    Journal of internal medicine, 1996, Volume: 240, Issue:1

    Topics: Coronary Disease; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Metformin; Risk Factors

1996
Homocysteine: the new player in the field of coronary risk.
    Heart (British Cardiac Society), 1996, Volume: 76, Issue:2

    Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex

1996
The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes.
    Biochemical and biophysical research communications, 1996, Sep-24, Volume: 226, Issue:3

    Topics: Coronary Disease; Erythrocytes; Glutathione; Hemolysis; Homocysteine; Humans; In Vitro Techniques; Kinetics; Luminescent Measurements; Neutrophils; Reference Values

1996
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.
    Atherosclerosis, 1996, Sep-27, Volume: 126, Issue:1

    Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Comorbidity; Coronary Disease; France; Homocysteine; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Odds Ratio; Risk; Risk Factors; Smoking; Survivors

1996
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Alanine; Alleles; Coronary Disease; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Temperature; Valine

1996
High prevalence of a mutation in the cystathionine beta-synthase gene.
    American journal of human genetics, 1996, Volume: 59, Issue:6

    Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Mutagenesis, Insertional; Polymerase Chain Reaction

1996
Perspective: a mechanism underlying homocysteinemia and increased risk of coronary artery and cerebrovascular disease.
    Circulation, 1996, Dec-01, Volume: 94, Issue:11

    Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Risk Factors

1996
Serum total homocysteine concentration and risk of stroke.
    Lancet (London, England), 1996, Nov-30, Volume: 348, Issue:9040

    Topics: Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Male; Odds Ratio; Risk Factors; United Kingdom

1996
[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
    Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Female; Folic Acid; France; Hematinics; Homocysteine; Humans; Male; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index

1996
Hyperhomocysteinaemia and the heart.
    QJM : monthly journal of the Association of Physicians, 1996, Volume: 89, Issue:11

    Topics: Coronary Disease; Homocysteine; Humans; Risk Factors

1996
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
    Heart (British Cardiac Society), 1996, Volume: 76, Issue:4

    Topics: Chronic Disease; Coronary Disease; Endothelium, Vascular; Gastritis; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Intestinal Absorption; Nutritional Status; Vitamin B Deficiency

1996
Methylenetetrahydrofolate reductase gene and coronary artery disease.
    Circulation, 1997, Jan-07, Volume: 95, Issue:1

    Topics: Adult; Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Random Allocation; Risk Factors

1997
[Basal homocysteinemia or following a methionine load. Which is the better indicator of coronary disease risk?].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1996, Volume: 15, Issue:12

    Topics: Case-Control Studies; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Time Factors

1996
Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia.
    The American journal of cardiology, 1997, Mar-01, Volume: 79, Issue:5

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Cholesterol, HDL; Coronary Disease; Female; Homocysteine; Humans; Intermittent Claudication; Risk Factors

1997
[Moderate hyper-homocysteinemia and coronary involvement].
    Presse medicale (Paris, France : 1983), 1996, Dec-21, Volume: 25, Issue:40

    Topics: Coronary Disease; Homocysteine; Humans; Middle Aged

1996
Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:3

    Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors

1997
Homocysteine and coronary artery disease.
    American journal of critical care : an official publication, American Association of Critical-Care Nurses, 1997, Volume: 6, Issue:1

    Topics: Adult; Coronary Disease; Folic Acid; Homocysteine; Homocystinuria; Humans; Male; Risk Factors

1997
Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.
    Circulation, 1997, Apr-15, Volume: 95, Issue:8

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Aged, 80 and over; Alleles; Asian People; Canada; Comorbidity; Coronary Disease; Disease Susceptibility; Gene Frequency; Genotype; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Polymorphism, Genetic; Risk Factors; White People

1997
Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
    Heart (British Cardiac Society), 1997, Volume: 77, Issue:4

    Topics: Asian People; Coronary Disease; Homocysteine; Humans; Vitamin B 6 Deficiency

1997
Homocysteinaemia and coronary atherosclerosis.
    Heart (British Cardiac Society), 1997, Volume: 77, Issue:4

    Topics: Asian People; Coronary Disease; Cystathionine beta-Synthase; Homocysteine; Humans

1997
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:6

    Topics: Alleles; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Regression Analysis; Risk Factors; Vitamins

1997
[Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor].
    Journal of cardiology, 1997, Volume: 29, Issue:6

    Topics: Adult; Asian People; Coronary Disease; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors

1997
Plasma homocysteine levels and mortality in patients with coronary artery disease.
    The New England journal of medicine, 1997, Jul-24, Volume: 337, Issue:4

    Topics: Adult; Aged; Cause of Death; Coronary Angiography; Coronary Disease; Creatinine; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke Volume; Survival Analysis

1997
[Homocysteine in case of coronary disease].
    Presse medicale (Paris, France : 1983), 1997, Jun-07, Volume: 26, Issue:19

    Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors

1997
Expanding and understanding risk factors for coronary heart disease.
    JAMA, 1997, Aug-27, Volume: 278, Issue:8

    Topics: Coronary Disease; Homocysteine; Humans; Life Style; Risk Factors

1997
Another cause of hyperhomocysteinemia.
    Hospital practice (1995), 1997, Aug-15, Volume: 32, Issue:8

    Topics: Arteriosclerosis; Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans

1997
Hyperhomocysteinemia is a risk factor for coronary artery disease even in the presence of elevated high-density lipoprotein cholesterol.
    The American journal of cardiology, 1997, Sep-01, Volume: 80, Issue:5

    Topics: Cholesterol, HDL; Coronary Disease; Homocysteine; Humans; Risk Factors

1997
Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?
    Southern medical journal, 1997, Volume: 90, Issue:9

    Topics: Adult; Analysis of Variance; Brain Ischemia; Carotid Artery Diseases; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Free Radicals; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Male; Methionine; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Sulfonylurea Compounds; Thiobarbiturates

1997
Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status.
    Medical hypotheses, 1997, Volume: 49, Issue:4

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Biological Availability; Coronary Disease; Folic Acid; Folic Acid Deficiency; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Intestinal Absorption; Models, Biological

1997
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Circulation, 1997, Oct-21, Volume: 96, Issue:8

    Topics: Adult; Coronary Disease; Homocysteine; Homocystine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies

1997
Association between plasma homocysteine and coronary artery disease in older persons.
    The American journal of cardiology, 1997, Nov-01, Volume: 80, Issue:9

    Topics: Age Factors; Aged; Aged, 80 and over; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Prevalence; Sex Factors; Vitamin B 12

1997
Hyperhomocysteinaemia.
    Postgraduate medical journal, 1997, Volume: 73, Issue:863

    Topics: Coronary Disease; Homocysteine; Humans; Risk Factors; Smoking

1997
[Blood levels of homocysteine in patients under 55 years of age with acute coronary insufficiency].
    Presse medicale (Paris, France : 1983), 1997, Oct-11, Volume: 26, Issue:30

    Topics: Acute Disease; Adult; Coronary Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Reproducibility of Results; Risk Factors

1997
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Age of Onset; Aged; Bilirubin; Case-Control Studies; Cholesterol, HDL; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Smoking; Survivors; Utah

1997
Plasma homocysteine levels and mortality in patients with coronary artery disease.
    The New England journal of medicine, 1997, Nov-27, Volume: 337, Issue:22

    Topics: Coronary Disease; Homocysteine; Humans; Risk Factors

1997
Plasma homocysteine levels and mortality in patients with coronary artery disease.
    The New England journal of medicine, 1997, Nov-27, Volume: 337, Issue:22

    Topics: Coronary Disease; Folic Acid; Homocysteine; Humans; Risk Factors

1997
Plasma homocysteine levels and mortality in patients with coronary artery disease.
    The New England journal of medicine, 1997, Nov-27, Volume: 337, Issue:22

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Blood Proteins; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors

1997
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
    Heart (British Cardiac Society), 1997, Volume: 78, Issue:5

    Topics: Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Risk; Risk Factors

1997
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.
    Heart (British Cardiac Society), 1997, Volume: 78, Issue:5

    Topics: Coronary Disease; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Risk; Risk Factors

1997
Preventing coronary heart disease: B vitamins and homocysteine.
    Circulation, 1998, Feb-10, Volume: 97, Issue:5

    Topics: Cerebrovascular Disorders; Coronary Disease; Folic Acid; Homocysteine; Humans; Peripheral Vascular Diseases; Pyridoxine; Vitamins

1998
Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
    Circulation, 1998, Feb-10, Volume: 97, Issue:5

    Topics: Adult; Analysis of Variance; Arteriosclerosis; Avitaminosis; Case-Control Studies; Cerebrovascular Disorders; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Pyridoxine; Risk Factors; Vascular Diseases; Vitamins

1998
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
    Metabolism: clinical and experimental, 1998, Volume: 47, Issue:3

    Topics: Adult; Body Constitution; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cysteine; Female; Fibrinogen; Glutathione; Homocysteine; Humans; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Characteristics; Triglycerides; Uric Acid

1998
Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study.
    Atherosclerosis, 1998, Volume: 137, Issue:1

    Topics: Adult; Aged; Alleles; Apolipoprotein E4; Apolipoproteins E; Case-Control Studies; Coronary Disease; Data Interpretation, Statistical; Demography; Female; Genotype; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors

1998
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Disease; Diabetes Mellitus; Disease Susceptibility; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Hot Temperature; Humans; Hyperlipidemias; Hypertension; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Prevalence; Protein Denaturation; Recurrence; Risk Factors; Smoking

1998
Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease.
    Clinical biochemistry, 1998, Volume: 31, Issue:2

    Topics: Age of Onset; Aged; Autoanalysis; Chromatography, High Pressure Liquid; Coronary Disease; Disease Susceptibility; Genetic Variation; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation

1998
Association of mild hyperhomocysteinemia with cardiac graft vascular disease.
    Atherosclerosis, 1998, Volume: 138, Issue:2

    Topics: Adult; Case-Control Studies; Coronary Disease; Heart Transplantation; Homocysteine; Humans; Middle Aged; Risk Factors

1998
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
    Circulation, 1998, Jul-21, Volume: 98, Issue:3

    Topics: Arteriosclerosis; Cohort Studies; Coronary Disease; Dietary Supplements; Fasting; Female; Folic Acid; Homocysteine; Humans; Incidence; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Pyridoxal Phosphate; Risk Factors; Vitamin B 12

1998
International Diabetes Federation Meeting, 1997, and other recent meetings. Atherosclerosis and related topics.
    Diabetes care, 1998, Volume: 21, Issue:8

    Topics: Antioxidants; Arteriosclerosis; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Homocysteine; Humans; Risk Factors

1998
A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:2

    Topics: Adult; Aged; Alleles; Case-Control Studies; Confidence Intervals; Coronary Disease; Diet; Folic Acid; Follow-Up Studies; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Pyridoxine; Riboflavin; Risk Factors; Smoking; United States; Vitamin B 12

1998
The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease.
    Clinical chemistry and laboratory medicine, 1998, Volume: 36, Issue:7

    Topics: Coronary Disease; Demography; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Lipids; Lipoproteins; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; ROC Curve; Surveys and Questionnaires; Vitamin B 12

1998
Improvement of coronary artery disease in a patient with hyperhomocysteinemia: report of a case.
    Nutrition (Burbank, Los Angeles County, Calif.), 1998, Volume: 14, Issue:9

    Topics: Adult; Angiography; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia

1998
Premenopausal black women have more risk factors for coronary heart disease than white women.
    The American journal of cardiology, 1998, Nov-01, Volume: 82, Issue:9

    Topics: Adolescent; Adult; Black or African American; Black People; Blood Pressure; Body Mass Index; Coronary Disease; Diet; Educational Status; Female; Homocysteine; Humans; Incidence; Least-Squares Analysis; Lipoproteins; Middle Aged; Oregon; Premenopause; Risk Factors; White People

1998
Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.
    Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:12

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cerebrovascular Disorders; Coronary Disease; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk

1998
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels.
    The American journal of cardiology, 1998, Dec-15, Volume: 82, Issue:12

    Topics: Aged; Coronary Disease; Exercise; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome

1998
[Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].
    Journal of cardiology, 1998, Volume: 32, Issue:6

    Topics: Aged; Coronary Artery Bypass; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Saphenous Vein; Vascular Patency

1998
Homocysteine levels and coronary heart disease in Syria.
    Journal of cardiovascular risk, 1998, Volume: 5, Issue:4

    Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Syria

1998
Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Age of Onset; Aged; Asian People; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Female; Gene Frequency; Homocysteine; Humans; Japan; Male; Middle Aged; Mutation; Polymorphism, Genetic

1999
Plasma homocysteine determined by capillary electrophoresis with laser-induced fluorescence detection.
    Clinical chemistry, 1999, Volume: 45, Issue:3

    Topics: Coronary Disease; Electrophoresis, Capillary; Fluorescence; Homocysteine; Humans; Lasers; Reproducibility of Results; Venous Thrombosis

1999
Beyond cholesterol.
    Time, 1997, Aug-04, Volume: 150, Issue:5

    Topics: Cholesterol; Coronary Disease; Feeding Behavior; Homocysteine; Humans; Norway; Risk Factors; United States; Vegetables

1997
Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
    Atherosclerosis, 1999, Volume: 143, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Age of Onset; Coronary Disease; Cystathionine beta-Synthase; Fasting; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic

1999
Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
    Heart (British Cardiac Society), 1999, Volume: 81, Issue:5

    Topics: Case-Control Studies; Cholesterol; Coronary Disease; Folic Acid; Genotype; Homocysteine; Humans; Lipoproteins, HDL; Methylenetetrahydrofolate Dehydrogenase (NADP); Odds Ratio; Polymerase Chain Reaction; Regression Analysis; Risk; Turkey; Vitamin B 12

1999
Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: the Bogalusa Heart Study.
    Circulation, 1999, Apr-27, Volume: 99, Issue:16

    Topics: Adolescent; Adult; Age Factors; Biomarkers; Black People; Blood Pressure; Body Mass Index; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Female; Homocysteine; Humans; Louisiana; Male; Parents; Risk Factors; Sex Characteristics; Skinfold Thickness; Triglycerides; White People

1999
Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Cerebrovascular Disorders; Coronary Disease; Creatinine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Male; Middle Aged; Prevalence; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome

1999
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men.
    International journal of epidemiology, 1999, Volume: 28, Issue:3

    Topics: Aged; Blood Glucose; Blood Pressure; Coronary Disease; Czechoslovakia; Fibrinogen; Germany; Homocysteine; Humans; Israel; Lipoproteins; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides

1999
Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women.
    The American journal of clinical nutrition, 1999, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Black People; Coronary Disease; Feeding Behavior; Female; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Premenopause; Reference Values; Surveys and Questionnaires; Vitamin B 12; White People

1999
Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
    Atherosclerosis, 1999, Volume: 145, Issue:1

    Topics: Coronary Disease; Fasting; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Male; Middle Aged; Vitamin B 12

1999
Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:9

    Topics: Adult; Aged; Coronary Disease; Creatinine; Cystatin C; Cystatins; Fasting; Female; Homocysteine; Humans; Kidney; Male; Middle Aged; Predictive Value of Tests; Reference Values

1999
Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population.
    Atherosclerosis, 1999, Volume: 146, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Age Distribution; Aged; Analysis of Variance; Australia; Coronary Disease; Cystathionine beta-Synthase; Female; Homocysteine; Hospitals; Humans; Incidence; Logistic Models; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Population Surveillance; Risk Factors; Severity of Illness Index; Sex Distribution

1999
Homocysteine and coronary artery disease.
    Atherosclerosis, 1999, Volume: 145, Issue:2

    Topics: Biomarkers; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Pteroylpolyglutamic Acids; Risk Factors; Severity of Illness Index

1999
Serum total homocysteine and coronary heart disease: prospective study in middle aged men.
    Heart (British Cardiac Society), 1999, Volume: 82, Issue:4

    Topics: Adult; Age Factors; Biomarkers; Case-Control Studies; Coronary Disease; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Risk Factors

1999
A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation.
    Circulation, 1999, Oct-05, Volume: 100, Issue:14

    Topics: Adult; Aged; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Exercise Test; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Risk Factors

1999
Plasma homocysteine level and development of coronary artery disease.
    Coronary artery disease, 1999, Volume: 10, Issue:7

    Topics: Adult; Age of Onset; Aged; Coronary Artery Disease; Coronary Disease; Homocysteine; Humans; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index

1999
[Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
    Medicina clinica, 1999, Oct-09, Volume: 113, Issue:11

    Topics: Aged; Case-Control Studies; Confidence Intervals; Coronary Disease; Creatinine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio

1999
Serum glutathione in adolescent males predicts parental coronary heart disease.
    Circulation, 1999, Nov-30, Volume: 100, Issue:22

    Topics: Adolescent; Aged; Anthropometry; Blood Pressure; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Coronary Disease; Glutathione; Homocysteine; Humans; Lipids; Logistic Models; Male; Middle Aged; Ohio; Oxidation-Reduction; Oxidative Stress; Parents; Sulfhydryl Compounds

1999
[Plasma homocysteine is not a predictive factor of restenosis after coronary angioplasty].
    Archives des maladies du coeur et des vaisseaux, 1999, Volume: 92, Issue:11

    Topics: Aged; Angioplasty, Balloon; Biomarkers; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence

1999
Homocysteine and cardiovascular diseases.
    Circulation, 1999, Dec-21, Volume: 100, Issue:25

    Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Male; Risk Factors

1999
An alternative view of homocysteine.
    Lancet (London, England), 1999, Dec-11, Volume: 354, Issue:9195

    Topics: Arterial Occlusive Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Risk Factors

1999
Similarities in the epidemiology of neural tube defects and coronary heart disease: is homocysteine the missing link?
    Journal of epidemiology and community health, 1999, Volume: 53, Issue:12

    Topics: Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Ireland; Male; Neural Tube Defects; Public Health; United Kingdom

1999
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:2

    Topics: Adult; Aged; Coronary Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Risk Factors

2000
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.
    Lancet (London, England), 2000, Feb-12, Volume: 355, Issue:9203

    Topics: Case-Control Studies; Coronary Disease; Europe; Fasting; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Middle Aged; Risk Factors; United Kingdom; Vitamin B 12

2000
Low plasma folate in combination with the 677 C-->T methylenetetrahydrofolate reductase polymorphism is associated with increased risk of coronary artery disease in Koreans.
    Thrombosis research, 2000, Jan-15, Volume: 97, Issue:2

    Topics: Adult; Aged; Asian People; Cardiac Catheterization; Coronary Disease; Female; Folic Acid; Gene Frequency; Homocysteine; Humans; Hyperhomocysteinemia; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Sex Factors; Vitamin B 12

2000
Plasma total homocysteine levels in subjects with hyperinsulinemia.
    Journal of internal medicine, 2000, Volume: 247, Issue:2

    Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Folic Acid; Glucose Tolerance Test; Homocysteine; Humans; Hyperhomocysteinemia; Hyperinsulinism; Insulin; Insulin Resistance; Life Style; Linear Models; Male; Middle Aged; Risk Factors

2000
Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
    Journal of epidemiology and community health, 2000, Volume: 54, Issue:1

    Topics: Adult; Aged; Biomarkers; China; Coronary Disease; Cross-Sectional Studies; Disease Susceptibility; Female; Homocysteine; Humans; India; Malaysia; Male; Middle Aged; Sex Factors; Singapore; Vitamin B 12

2000
Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients.
    Nutrition (Burbank, Los Angeles County, Calif.), 2000, Volume: 16, Issue:2

    Topics: Antioxidants; Ascorbic Acid; beta Carotene; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Vitamin B 12; Vitamin E; Vitamins

2000
Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:3

    Topics: Adult; Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Portugal

2000
The homocysteine question.
    Lancet (London, England), 2000, Apr-01, Volume: 355, Issue:9210

    Topics: Coronary Disease; Cystine; Homocysteine; Homocystinuria; Humans

2000
[Homocysteinemia: role in vascular disease].
    Presse medicale (Paris, France : 1983), 2000, Apr-08, Volume: 29, Issue:13

    Topics: Cerebral Infarction; Coronary Disease; Homocysteine; Humans; Risk Factors; Vascular Diseases

2000
Multicenter analytical evaluation of an automated immunoassay for total plasma homocysteine.
    Annals of clinical and laboratory science, 2000, Volume: 30, Issue:2

    Topics: Chemistry, Clinical; Chromatography, High Pressure Liquid; Coronary Disease; Evaluation Studies as Topic; Homocysteine; Humans; Immunoassay; Reference Values; Regression Analysis; Sensitivity and Specificity

2000
Homocysteine, vitamins B6, B12, folate, and risk of coronary artery disease in patients undergoing diagnostic coronary angiography.
    Amino acids, 2000, Volume: 18, Issue:2

    Topics: Aged; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Pyridoxine; Risk Factors; Vitamin B 12

2000
Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    European journal of clinical nutrition, 2000, Volume: 54, Issue:5

    Topics: Adult; Cardiovascular Diseases; Carotenoids; Cohort Studies; Coronary Disease; Finland; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Lycopene; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors

2000
Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2000, Volume: 83, Issue:5

    Topics: Aged; Analysis of Variance; Biomarkers; Case-Control Studies; Coronary Disease; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Male; Middle Aged; Pteroylpolyglutamic Acids; Reference Values; Sensitivity and Specificity; Thailand; Vitamin B 12

2000
Factors influencing plasma homocysteine levels in type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:3

    Topics: Albuminuria; Blood Pressure; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Reference Values; Regression Analysis; Triglycerides; Vitamins

2000
Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls.
    Nutrition (Burbank, Los Angeles County, Calif.), 2000, Volume: 16, Issue:6

    Topics: Aged; Arteriosclerosis; Cholesterol; Chromatography, High Pressure Liquid; Coronary Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Lipoproteins, HDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin E

2000
Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes.
    Archives of internal medicine, 2000, Jun-26, Volume: 160, Issue:12

    Topics: Acute Disease; Aged; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Patient Admission; Predictive Value of Tests; Prognosis; Prospective Studies; Risk; Survival Analysis; Sweden

2000
Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease.
    Pediatrics international : official journal of the Japan Pediatric Society, 2000, Volume: 42, Issue:3

    Topics: Case-Control Studies; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Female; Genotype; Homocysteine; Humans; Infant; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Mucocutaneous Lymph Node Syndrome; Mutation, Missense; Polymerase Chain Reaction; Polymorphism, Genetic; Sex Factors

2000
Homocysteine and heart disease in Indian Asians.
    Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222

    Topics: Coronary Disease; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; India; Risk Factors; United Kingdom; Vitamin B 12

2000
Homocysteine and heart disease in Indian Asians.
    Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222

    Topics: Coronary Disease; Europe; Homocysteine; Humans; India; Male; Risk Factors; Sex Factors; Social Class; United Kingdom

2000
Homocysteine and heart disease in Indian Asians.
    Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222

    Topics: Coronary Disease; Folic Acid; Folic Acid Deficiency; Fructose; Homocysteine; Humans; Hyperhomocysteinemia; India; Malabsorption Syndromes; United Kingdom; Vitamin B 12

2000
Homocysteine and heart disease in Indian Asians.
    Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222

    Topics: Coronary Disease; Diabetes Complications; Diet; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Homocysteine; Humans; India; Insulin Resistance; Risk Factors; United Kingdom; Urban Health

2000
Coronary heart disease in Indian Asians.
    Lancet (London, England), 2000, May-13, Volume: 355, Issue:9216

    Topics: Coronary Disease; Cross-Cultural Comparison; Cross-Sectional Studies; Developing Countries; Homocysteine; Humans; Incidence; India; Poverty; United Kingdom

2000
Coronary heart disease in Indian Asians.
    Lancet (London, England), 2000, May-13, Volume: 355, Issue:9216

    Topics: Coronary Disease; Cross-Cultural Comparison; Developing Countries; Diet, Vegetarian; Homocysteine; Humans; India; Risk Factors; United Kingdom

2000
Increased plasma homocysteine is an independent predictor of new coronary events in older persons.
    The American journal of cardiology, 2000, Aug-01, Volume: 86, Issue:3

    Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Vitamin B 12

2000
Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease.
    Atherosclerosis, 2000, Volume: 151, Issue:2

    Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Middle Aged; Odds Ratio; Postmenopause; Reference Values; Risk Factors; ROC Curve

2000
Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study.
    Atherosclerosis, 2000, Volume: 151, Issue:2

    Topics: Aged; Carotid Arteries; Coronary Disease; Fasting; Female; Homocysteine; Humans; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography

2000
Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.
    American heart journal, 2000, Volume: 140, Issue:2

    Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Recurrence; Risk Factors

2000
Homocysteine as a risk factor for restenosis after coronary angioplasty.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Recurrence; Risk Factors; Sensitivity and Specificity; Smoking

2000
Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Journal of internal medicine, 2000, Volume: 248, Issue:3

    Topics: Adult; Analysis of Variance; Case-Control Studies; Confounding Factors, Epidemiologic; Coronary Disease; Finland; Homocysteine; Humans; Incidence; Male; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors

2000
Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents.
    Diabetes care, 2000, Volume: 23, Issue:9

    Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Cholesterol; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Insulin; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Obesity; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Regression Analysis; Risk Factors; Triglycerides; Vitamin B 12

2000
Global risk assessment for lipid therapy to prevent coronary heart disease.
    Current cardiology reports, 2000, Volume: 2, Issue:5

    Topics: Blood Flow Velocity; Carotid Arteries; Coronary Disease; Exercise Test; Gemfibrozil; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Risk Assessment; Risk Factors; Tunica Intima

2000
A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease.
    Journal of cardiovascular risk, 2000, Volume: 7, Issue:3

    Topics: Age Factors; Base Sequence; Coronary Disease; Data Interpretation, Statistical; Female; Ferredoxin-NADP Reductase; Flavoproteins; Folic Acid; Genotype; Homocysteine; Humans; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk; Sex Factors; Vitamin B 12

2000
Primary prevention of coronary heart disease: from controversy to consensus.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2000, Volume: 10, Issue:3

    Topics: Algorithms; Biomarkers; Coronary Disease; Diagnostic Imaging; Homocysteine; Humans; Metabolism, Inborn Errors; Risk Factors

2000
[The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Zhonghua yi xue za zhi, 1998, Volume: 78, Issue:11

    Topics: Adult; Aged; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Risk Factors

1998
Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:11

    Topics: Adult; Alleles; Case-Control Studies; Coronary Disease; Genotype; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; United Kingdom

2000
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
    Clinical biochemistry, 2000, Volume: 33, Issue:6

    Topics: Adult; Cholesterol; Coronary Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Triglycerides

2000
Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease.
    Diabetes research and clinical practice, 2000, Volume: 50, Issue:3

    Topics: Albuminuria; Biomarkers; Blood Pressure; Coronary Disease; Creatinine; Cystatin C; Cystatins; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Homocysteine; Humans; Kidney Function Tests; Male; Middle Aged

2000
Influence of 699C-->T and 1080C-->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels.
    Clinical genetics, 2000, Volume: 58, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Cystathionine beta-Synthase; Fasting; Female; Genotype; Homocysteine; Humans; Male; Methionine; Middle Aged; Point Mutation; Polymorphism, Genetic

2000
Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia.
    Journal of cardiovascular risk, 2000, Volume: 7, Issue:6

    Topics: Adult; Aged; Coronary Disease; Female; Genotype; Homocysteine; Humans; Hypercholesterolemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multifactorial Inheritance; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors

2000
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.
    Heart (British Cardiac Society), 2001, Volume: 85, Issue:2

    Topics: Biomarkers; Case-Control Studies; Coronary Disease; Diet; Follow-Up Studies; Homocysteine; Humans; Linear Models; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking

2001
Homocysteine and the MTHFR 677C-->T allele in premature coronary artery disease. Case control and family studies.
    European journal of clinical investigation, 2001, Volume: 31, Issue:1

    Topics: Adult; Age of Onset; Case-Control Studies; Coronary Disease; Family Health; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors

2001
Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing.
    American journal of medical genetics, 2000, Dec-11, Volume: 95, Issue:4

    Topics: Adolescent; Adult; Aged; Alternative Splicing; Coronary Disease; Cystathionine beta-Synthase; Exons; Female; Gene Frequency; Homocysteine; Humans; Introns; Male; Middle Aged; Minisatellite Repeats; Polymorphism, Genetic

2000
[Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:1

    Topics: Aged; Coronary Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Predictive Value of Tests; Risk Factors

2001
Multivitamin supplements are effective and inexpensive agents to lower homocysteine levels.
    Archives of internal medicine, 2001, Mar-12, Volume: 161, Issue:5

    Topics: Coronary Disease; Dietary Supplements; Homocysteine; Humans; Treatment Outcome; Vitamins

2001
Hyperhomocysteinemia and restenosis.
    Journal of cardiovascular risk, 2001, Volume: 8, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Risk Factors; Stents

2001
Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease.
    Atherosclerosis, 2001, Feb-15, Volume: 154, Issue:3

    Topics: Coronary Disease; Gene Frequency; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic

2001
The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease.
    International journal of cardiology, 2001, Volume: 78, Issue:1

    Topics: Aged; Asian People; Coronary Disease; Female; Genotype; Homocysteine; Humans; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Phenotype; Polymorphism, Genetic

2001
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Clinical chemistry, 2001, Volume: 47, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Coronary Disease; Fasting; Female; Fluorometry; Genotype; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Venous Thrombosis

2001
Effect of age and sex on plasma total homocysteine in Taiwanese subjects.
    The Chinese journal of physiology, 2000, Dec-31, Volume: 43, Issue:4

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Renal Dialysis; Risk Factors; Sex Distribution; Taiwan; Uremia

2000
Association between plasma folate and coronary disease independent of homocysteine.
    The American journal of cardiology, 2001, Apr-15, Volume: 87, Issue:8

    Topics: Case-Control Studies; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Risk Factors

2001
Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia.
    American journal of medical genetics, 2001, Jun-01, Volume: 101, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Alleles; Case-Control Studies; Coronary Disease; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors

2001
Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:5

    Topics: Adult; Aged; Coronary Artery Disease; Coronary Disease; Creatinine; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Renal Insufficiency; Risk Factors; Vitamin B 12

2001
Homocysteine and major coronary events: a prospective population study amongst women.
    Journal of internal medicine, 2001, Volume: 249, Issue:5

    Topics: Adult; Case-Control Studies; Coronary Disease; Female; Finland; Homocysteine; Humans; Population Surveillance; Prospective Studies; Risk Factors

2001
Screening for hyperhomocysteinemia in young adults with premature coronary artery disease.
    The Southeast Asian journal of tropical medicine and public health, 1999, Volume: 30 Suppl 2

    Topics: Age of Onset; Chromatography, High Pressure Liquid; Coronary Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors

1999
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
    Archives of internal medicine, 2001, Jul-09, Volume: 161, Issue:13

    Topics: Case-Control Studies; Cholesterol; Confounding Factors, Epidemiologic; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires

2001
Serum homocysteine does not associate with uncomplicated coronary heart disease.
    European journal of clinical investigation, 2001, Volume: 31, Issue:7

    Topics: Aged; Angina Pectoris; Coronary Disease; Finland; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors

2001
Homocysteine: a novel risk factor for coronary heart disease in UK Indian Asians.
    Heart (British Cardiac Society), 2001, Volume: 86, Issue:2

    Topics: Biomarkers; Coronary Disease; Homocysteine; Humans; India; Risk Factors; United Kingdom

2001
Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
    The American journal of cardiology, 2001, Aug-01, Volume: 88, Issue:3

    Topics: Calcium; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Metabolic Diseases; Middle Aged; Risk Factors; Tomography, X-Ray Computed

2001
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.
    Diabetes care, 2001, Volume: 24, Issue:8

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Coronary Disease; Creatinine; Fasting; Female; Folic Acid; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Massachusetts; Middle Aged; Risk Factors; Sex Factors; Vitamin B 12

2001
Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2001, Volume: 49, Issue:4

    Topics: Aged; Apolipoproteins B; Case-Control Studies; Cholesterol; Chronic Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoprotein(a); Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Liver Diseases; Methionine; Middle Aged; Risk Factors; Triglycerides

2001
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cohort Studies; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus; Female; Hemoglobin A; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peripheral Vascular Diseases; Prevalence; Prospective Studies

2001
Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal community.
    The American journal of clinical nutrition, 2001, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Antioxidants; Australia; Cholesterol; Community Health Services; Coronary Disease; Diet; Female; Homocysteine; Humans; Life Style; Male; Native Hawaiian or Other Pacific Islander; Risk Factors; Sex Distribution

2001
Extent of coronary atherosclerosis and homocysteine affect endothelial markers.
    Angiology, 2001, Volume: 52, Issue:9

    Topics: Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Disease; E-Selectin; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Vascular Cell Adhesion Molecule-1

2001
Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
    Chinese medical journal, 1999, Volume: 112, Issue:7

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Risk Factors; Vitamin B 12

1999
Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease.
    Clinical transplantation, 2001, Volume: 15, Issue:4

    Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Creatinine; Cross-Sectional Studies; Female; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Vitamin B 12; Vitamin B 6

2001
Hyperhomocysteinemia and transplant coronary artery disease in cardiac transplant recipients.
    Clinical transplantation, 2001, Volume: 15, Issue:4

    Topics: Adult; Coronary Angiography; Coronary Disease; Female; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged

2001
[Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].
    Zhonghua yi xue za zhi, 1999, Volume: 79, Issue:6

    Topics: Adult; Coronary Disease; Cystathionine beta-Synthase; Female; Gene Frequency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

1999
Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
    Archives of internal medicine, 2001, Nov-26, Volume: 161, Issue:21

    Topics: Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors

2001
[The association between plasma homocysteine and the number of coronary artery with stenosis].
    Zhonghua nei ke za zhi, 1999, Volume: 38, Issue:12

    Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Risk Factors; Sex Factors

1999
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.
    Atherosclerosis, 2002, Volume: 160, Issue:2

    Topics: 4-Butyrolactone; Coronary Disease; Estrogens; F2-Isoprostanes; Homocysteine; Humans; Lignans; Lipid Peroxidation; Male; Middle Aged; Multivariate Analysis; Risk Factors

2002
Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis.
    The American journal of cardiology, 2002, Mar-01, Volume: 89, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Vitamin B 12

2002
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
    The American journal of cardiology, 2002, Mar-01, Volume: 89, Issue:5

    Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Prediabetic State; Risk Factors

2002
Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.
    International journal of cardiology, 2002, Volume: 82, Issue:3

    Topics: Aged; Case-Control Studies; Coronary Disease; Cysteine; Dipeptides; Female; Folic Acid; Homocysteine; Humans; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12

2002
[Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
    Deutsche medizinische Wochenschrift (1946), 2002, Apr-05, Volume: 127, Issue:14

    Topics: Case-Control Studies; Coronary Disease; Female; Folic Acid; Genotype; Germany; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors; Vitamin B 12

2002
Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes.
    Clinical chemistry and laboratory medicine, 2002, Volume: 40, Issue:2

    Topics: Acute Disease; Case-Control Studies; Coronary Disease; Cystatin C; Cystatins; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Vitamins

2002
Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians.
    Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Arteriosclerosis; Biomarkers; Body Mass Index; Child; Cholesterol; Chromatography, High Pressure Liquid; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Saudi Arabia; Triglycerides

2002
Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia.
    The American journal of cardiology, 2002, Apr-15, Volume: 89, Issue:8

    Topics: Adult; Age of Onset; Case-Control Studies; Coronary Disease; Female; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors

2002
Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:2

    Topics: Adult; Aged; Biomarkers; Collateral Circulation; Coronary Disease; Coronary Stenosis; Creatinine; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking

2002
[Homocysteine and coronary artery disease].
    Revista espanola de cardiologia, 2002, Volume: 55, Issue:5

    Topics: Coronary Disease; Homocysteine; Humans; Risk Factors

2002
Homocysteine, vitamin B6, and vascular disease in AD patients.
    Neurology, 2002, May-28, Volume: 58, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angina Pectoris; Brain Infarction; Coronary Disease; Female; Heart Failure; Homocysteine; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Odds Ratio; Pyridoxal Phosphate; Stroke; Vascular Diseases; Vitamin B 6

2002
Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
    Clinical science (London, England : 1979), 2002, Volume: 102, Issue:6

    Topics: Adult; Aged; Analysis of Variance; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Erythrocytes; Female; Folic Acid; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Stroke

2002
Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem.
    Circulation, 2002, Jun-11, Volume: 105, Issue:23

    Topics: Adolescent; Adult; Case-Control Studies; Cholesterol; Coronary Disease; Family Health; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Israel; Male; Myocardial Infarction; Risk Factors; United States

2002
Early and delayed increase in plasma homocysteine levels in heart transplanted patients.
    Transplantation proceedings, 2002, Volume: 34, Issue:4

    Topics: Analysis of Variance; Biomarkers; Cardiomyopathy, Dilated; Cholesterol; Coronary Disease; Creatinine; Female; Follow-Up Studies; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Postoperative Period; Regression Analysis; Retrospective Studies; Risk Factors; Time Factors; Triglycerides

2002
[Plasma homocysteine levels in Spanish patients with coronary artery disease].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:4

    Topics: Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Spain

2002
Homocysteine and C-reactive protein levels in haemodialysis patients.
    International urology and nephrology, 2001, Volume: 33, Issue:2

    Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Vitamin B 12

2001
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
    The Journal of clinical investigation, 1976, Volume: 57, Issue:4

    Topics: Coronary Disease; Cystine; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged

1976
Molecular genetics and genetic epidemiology of cardiovascular diseases and diabetes. Introductory remarks: risk factor levels and variability.
    Annals of medicine, 1992, Volume: 24, Issue:5

    Topics: Aged; Aged, 80 and over; Apolipoproteins; Arteriosclerosis; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Chromosome Mapping; Coronary Disease; Diabetes Mellitus; Genes; Genetic Variation; Glycoproteins; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Polymorphism, Genetic; Receptors, LDL; Risk Factors; Triglycerides

1992
Plasma folate adequacy as determined by homocysteine level.
    Annals of the New York Academy of Sciences, 1992, Sep-30, Volume: 669

    Topics: Adult; Arterial Occlusive Diseases; Biological Assay; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Reference Values

1992
Population variation and genetics of plasma homocyst(e)ine level.
    Clinical genetics, 1992, Volume: 41, Issue:6

    Topics: Adult; Analysis of Variance; Apolipoproteins; Coronary Disease; Female; Fibrinogen; Homocysteine; Homocystine; Humans; Lipids; Male; Middle Aged; Norway; Twins; Twins, Dizygotic; Twins, Monozygotic

1992
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.
    JAMA, 1992, Aug-19, Volume: 268, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Disease; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Regression Analysis; Risk Factors; United States

1992
Homocysteine content of plasma in ischemic heart disease, the reducing effect of pyridoxine, folate, cobalamin, choline, riboflavin and troxerutin. Correction of a calculation error.
    Atherosclerosis, 1991, Volume: 88, Issue:1

    Topics: Amino Acids; Anticoagulants; Choline; Coronary Disease; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Pyridoxine; Riboflavin; Vitamin B 12

1991
The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.
    Klinische Wochenschrift, 1991, Aug-16, Volume: 69, Issue:12

    Topics: Adult; Cholesterol; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Homocysteine; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors

1991
Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.
    American journal of human genetics, 1991, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Coronary Disease; Enzyme Activation; Female; Gene Frequency; Genes, Recessive; Genetic Carrier Screening; Genetic Variation; Homocysteine; Hot Temperature; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors

1991
Hyperhomocysteinemia: an independent risk factor for vascular disease.
    The New England journal of medicine, 1991, Apr-25, Volume: 324, Issue:17

    Topics: Cerebrovascular Disorders; Coronary Disease; Cystathionine beta-Synthase; Female; Heterozygote; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Vascular Diseases

1991
Plasma homocyst(e)ine levels in men with premature coronary artery disease.
    Journal of the American College of Cardiology, 1990, Volume: 16, Issue:5

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Homocysteine; Homocystinuria; Humans; Male; Middle Aged; Reference Values; Risk Factors

1990
Plasma glucosamine and galactosamine in ischemic heart disease.
    Atherosclerosis, 1990, Volume: 82, Issue:1-2

    Topics: Adult; Arteriosclerosis; Cholesterol; Chromatography, Ion Exchange; Coronary Disease; Galactosamine; Glucosamine; Glycoproteins; Glycosaminoglycans; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values

1990
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
    Atherosclerosis, 1989, Volume: 75, Issue:1

    Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Lipids; Male; Middle Aged; Pyridoxine; Riboflavin; Vitamin B 12

1989
Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion.
    Circulation research, 1988, Volume: 63, Issue:1

    Topics: Adenosine; Adenosylhomocysteinase; Animals; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Homocysteine; Hydrogen-Ion Concentration; Hydrolases; Myocardium; Perfusion; S-Adenosylhomocysteine

1988
Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:5

    Topics: Adult; Age Factors; Aged; Blood Proteins; Coronary Disease; Female; Homocysteine; Homocystine; Humans; Male; Menopause; Middle Aged; Protein Binding; Risk; Sex Factors

1986
Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia.
    Biochimica et biophysica acta, 1985, Jul-05, Volume: 840, Issue:3

    Topics: Adenosine; Adenosylhomocysteinase; Animals; Coronary Disease; Homocysteine; Hydrolases; In Vitro Techniques; Kinetics; Male; Myocardium; Perfusion; Rats; Rats, Inbred Strains

1985